syndrome	score	normalized_score
DRAVET SYNDROME	2.6698290399999998	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	56.96023330392722
MYOCLONIC-ASTASTIC EPILEPSY	1.223545494	45.828608336659634
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.71050326128747
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1564266	43.31463111211047
RING CHROMOSOME 12 SYNDROME	1.011719094	37.894527284039135
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.003811773	37.598353975504
EHLERS-DANLOS SYNDROME, TYPE I	1.00163132	37.516683839801225
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.47586096374171
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.000541419	37.47586096374171
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.45558180009908
RADIAL HEMIMELIA	1.0	37.45558180009908
ANAPLASTIC THYROID CARCINOMA	1.0	37.45558180009908
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.45558180009908
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.00002232352675
LAFORA DISEASE	0.7715289599999999	28.898066072425372
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.863911825605136
CRANIOSYNOSTOSIS 4; CRS4	0.75406504	28.243944788314984
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.038460619935424
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.545853812422386
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.688410474	25.784814820951986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.654470273	24.51356484608468
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59705175	22.36292066101731
ROLANDIC EPILEPSY	0.5906213	22.122064415030863
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.5720198999999999	21.425338155734494
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.55880235	20.930267130512597
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5552362999999999	20.79669865303435
COG5-CDG	0.546916009	20.485057312883228
BRACHYDACTYLY TYPE A2	0.5397618	20.21709225246872
TRICHO-DENTO-OSSEOUS SYNDROME	0.5357143	20.06549078513282
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	19.976297808192246
MENINGIOMA	0.5277778	19.768224560176336
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.74010290936082
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.520093814	19.480416394002518
TRICHODENTOOSSEOUS SYNDROME	0.52	19.476902536051526
W SYNDROME	0.517208404	19.372341683720695
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.50840336	19.04254363792522
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.50840336	19.04254363792522
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.99156247098129
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.5047518799999999	18.905775330093793
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.50433402	18.89012414068281
BRACHYDACTYLY TYPE C	0.5027248	18.82984986933845
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5027027	18.82902210098067
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.500545554	18.748224942522913
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.500545554	18.748224942522913
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.500545554	18.748224942522913
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.500541419	18.74807006369217
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.500541419	18.74807006369217
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.72779090004954
INHALATIONAL ANTHRAX	0.5	18.72779090004954
BRACHYDACTYLY, TYPE D	0.5	18.72779090004954
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	18.72779090004954
CREST SYNDROME	0.5	18.72779090004954
613241 PSEUDOPILI ANNULATI	0.5	18.72779090004954
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.5	18.72779090004954
RESTRICTIVE DERMOPATHY	0.5	18.72779090004954
MADELUNG DEFORMITY	0.5	18.72779090004954
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	18.72779090004954
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.72779090004954
PAROXYSMAL HEMICRANIA	0.5	18.72779090004954
GLOMUVENOUS MALFORMATION	0.492857	18.460245679251432
POLAND SYNDROME	0.4888886	18.311606948435923
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43744392	16.384716528515998
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.4346148040000001	16.278750342756034
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.4250511900000001	15.920539616274459
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41513130400000003	15.548984514753803
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.315261534498855
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40455521	15.152850760811262
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.383130283	14.35036765500161
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.381884434	14.303703655871539
PLACENTAL INSUFFICIENCY	0.3768113	14.113686470351677
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.36722242	13.754529391140341
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.65480353004176
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.39103195911001
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.39103195911001
CENTRALOPATHIC EPILEPSY	0.3547009	13.285528574518764
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.35182059400000004	13.17764503752645
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.34968319400000003	13.097587476986918
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.348514173	13.053801115295382
NON-DISTAL MONOSOMY 20Q	0.345635419	12.94597570936602
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.915707142057306
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.3438593	12.879450138874809
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34336768	12.861036225750247
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.831992418510813
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.748953019104176
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.33888856	12.693268180197787
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.338015933	12.660583428218311
PELVIS-SHOULDER DYSPLASIA	0.3360357	12.586412649103556
EPIDERMAL NEVUS SYNDROME	0.333878554	12.5056154906458
COG4-CDG	0.333878554	12.5056154906458
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333874419	12.505460611815057
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.333333	12.485181448172428
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.333333	12.485181448172428
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.485181448172428
PERIPARTUM CARDIOMYOPATHY	0.333333	12.485181448172428
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	12.485181448172428
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.485181448172428
BRACHYDACTYLY, TYPE A6	0.333333	12.485181448172428
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	12.485181448172428
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	12.485181448172428
NEUROMYELITIS OPTICA	0.333333	12.485181448172428
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.485181448172428
NEPHROPATHIC INFANTILE CYSTINOSIS	0.333333	12.485181448172428
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.284670646926516
DOORS SYNDROME	0.29093556400000004	10.897160815959964
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.28834590000000004	10.800163444173192
PALLISTER-HALL SYNDROME	0.277419384	10.390904430345099
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.27511509999999995	10.304596132492437
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.27238595	10.202374231422699
WILLIAMS SYNDROME	0.2718045800000001	10.180598679831578
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.266670419	9.988295692521197
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.2635135	9.87005145468041
DYSTONIA 6, TORSION	0.2635135	9.87005145468041
KEPPEN-LUBINSKY SYNDROME	0.260580429	9.760191573914412
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.259940294	9.736214945058807
OTOFACIOCERVICAL SYNDROME 2	0.25555556	9.57198218205013
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.254333723	9.526217566350242
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.25431034	9.525341742481011
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.253270354	9.486388461787051
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.252506059	9.457761347895145
INFANTILE MYOFIBROMATOSIS	0.2522581	9.448473899287574
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.252176874	9.44543153220028
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	9.437482184252518
CHROMOSOME 1P36 DELETION SYNDROME	0.251879933	9.434309434284977
DYSTONIA 28, CHILDHOOD-ONSET	0.250545554	9.384329492498141
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	9.384329492498141
HYPERPARATHYROIDISM 2	0.25	9.36389545002477
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.25	9.36389545002477
CONGENITAL FACTOR II DEFICIENCY	0.25	9.36389545002477
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.36389545002477
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	9.36389545002477
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25	9.36389545002477
NIJMEGEN BREAKAGE SYNDROME	0.25	9.36389545002477
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.25	9.36389545002477
SEVERE HEMOPHILIA A	0.25	9.36389545002477
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.25	9.36389545002477
HYPEREKPLEXIA 1; HKPX1	0.25	9.36389545002477
HEMOPHILIA B	0.25	9.36389545002477
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	9.36389545002477
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.25	9.36389545002477
DYSTONIA 16; DYT16	0.25	9.36389545002477
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.25	9.36389545002477
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	9.36389545002477
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.25	9.36389545002477
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25	9.36389545002477
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.25	9.36389545002477
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24649358999999998	9.232560823445086
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.10339764676468
TRICHOTHIODYSTROPHY	0.239213874	8.959894825325595
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.711093726061202
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.462307758851855
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.22510605000000003	8.431478069472195
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.221920273	8.312152938451819
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.220093814	8.243741853972793
JUVENILE HYALINE FIBROMATOSIS	0.22	8.240227996021797
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21876	8.193783074589676
8P INVERTED DUPLICATION/DELETION SYNDROME	0.216703309	8.11674851660165
KOOLEN-DE VRIES SYNDROME; KDVS	0.210782813	7.894992894376489
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.20915149300000002	7.833890854674353
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.20915149300000002	7.833890854674353
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.20840336	7.805869097895497
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.805869097895497
6P22 MICRODELETION SYNDROME	0.20718688	7.760305131747312
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.685447155073271
NORRIE DISEASE	0.204851759	7.672841816118684
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.204682933	7.666518340065701
CHROMOSOME 16P13.3 DELETION SYNDROME	0.203811773	7.633888535424727
BROOKE-SPIEGLER SYNDROME	0.203704	7.6298518350073845
HOLT-ORAM SYNDROME	0.20238130000000001	7.5803093369603936
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.20196464	7.564703094247563
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.201086973	7.531829566135816
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.201086973	7.531829566135816
SAY-BARBER-MILLER SYNDROME	0.20054555400000001	7.511550402493189
ROMANO-WARD SYNDROME	0.200541419	7.511395523662445
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.200541419	7.511395523662445
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.491116360019817
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	7.491116360019817
BETA-THALASSEMIA	0.2	7.491116360019817
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2	7.491116360019817
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.2	7.491116360019817
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.2	7.491116360019817
POLYARTERITIS NODOSA	0.2	7.491116360019817
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	7.491116360019817
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.491116360019817
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.2	7.491116360019817
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.2	7.491116360019817
BENIGN SCHWANNOMA	0.2	7.491116360019817
MALARIA	0.2	7.491116360019817
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.491116360019817
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.2	7.491116360019817
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.491116360019817
SAGLIKER SYNDROME	0.1909091	7.150611411433296
BILATERAL POLYMICROGYRIA	0.19069676400000002	7.142658243016191
TRISOMY 18	0.190529324	7.136386680399581
SCHINZEL-GIEDION SYNDROME	0.19047620000000004	7.134396890072034
MYOCLONIC EPILEPSY OF INFANCY	0.18559615399999999	6.951611927930785
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18559615399999999	6.951611927930785
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.1851855	6.93623064344225
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.853446316547669
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.180721919	6.769044620175381
ROIFMAN SYNDROME; RFMN	0.18038989400000002	6.756608430628204
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.17803989999999997	6.6685880381314595
MUCOLIPIDOSIS TYPE II	0.17570573	6.581160342761123
UNILATERAL POLYMICROGYRIA	0.17540910999999998	6.570050268087578
AURICULOOSTEODYSPLASIA	0.17473152	6.54467074041565
AURICULOOSTEODYSPLASIA	0.17473152	6.54467074041565
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.17460351000000002	6.539876051389419
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17369563300000002	6.505870990151491
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17367630399999998	6.505147011210875
CEREBROOCULONASAL SYNDROME	0.17236336	6.455969929819926
MICROTRIPLICATION 11Q24.1	0.1720945	6.445899622097152
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.171434473	6.421177926808378
268650 RUDIGER SYNDROME	0.17073204	6.394867890117789
LÉRI-WEILL DYSCHONDROSTEOSIS	0.17042891999999998	6.383514354162542
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.1693918	6.344668421166025
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.1693697	6.343840652808243
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.16926173400000002	6.339796723463613
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.16871618000000002	6.319362680990241
BRACHYDACTYLY, TYPE E	0.16871618000000002	6.319362680990241
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16846645399999996	6.310009048369627
ADULT-ONSET DYSTONIA-PARKINSONISM	0.167753973	6.283322657993113
BRANCHIOSKELETOGENITAL SYNDROME	0.167208419	6.262888615519742
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.262888615519742
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.166667	6.242609451877114
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.166667	6.242609451877114
BRACHYDACTYLY, TYPE B1	0.166667	6.242609451877114
BRACHYDACTYLY TYPE E	0.166667	6.242609451877114
DERMATOLEUKODYSTROPHY	0.166667	6.242609451877114
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.166667	6.242609451877114
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.166667	6.242609451877114
BRACHYDACTYLY TYPE B2	0.166667	6.242609451877114
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.166667	6.242609451877114
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.166667	6.242609451877114
BRACHYDACTYLY TYPE B	0.166667	6.242609451877114
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.242609451877114
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.166667	6.242609451877114
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.166667	6.242609451877114
SPINOCEREBELLAR ATAXIA 14	0.166667	6.242609451877114
SCALP-EAR-NIPPLE SYNDROME	0.166667	6.242609451877114
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.166667	6.242609451877114
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.163300214	6.116504523450685
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.1597745	5.984446854319931
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.974378793932064
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.974378793932064
RESTRICTIVE DERMOPATHY, LETHAL	0.15919687	5.96281138660474
FREE SIALIC ACID STORAGE DISEASE	0.158229673	5.926584460254429
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.15768825399999997	5.906305296611801
WRINKLY SKIN SYNDROME	0.15652817399999996	5.862853825277141
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.801751785575004
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.15484175	5.799687833195493
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.15362699299999996	5.754188403014748
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.718037062028511
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.718037062028511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.15260885999999999	5.716053639149869
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.15205635	5.695359055649496
DE BARSY SYNDROME	0.15180161399999997	5.685817770564065
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.67794782844972
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.14980678	5.611100102499448
PHACE SYNDROME	0.14956195299999997	5.601929964774074
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.149016399	5.581495922300704
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.56040472164465
EHLERS-DANLOS SYNDROME, TYPE VI	0.14719101999999998	5.51312528985002
DISTAL MONOSOMY 7Q36	0.14612321899999997	5.473130182148291
PIEBALDISM	0.14482163999999997	5.424378783444501
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.14394397299999998	5.391505255332753
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.143921334	5.390657298416382
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.14354070000000002	5.376400430493483
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.143402554	5.371226091690126
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14339841899999997	5.371071212859381
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.14339841899999997	5.371071212859381
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.350792049216754
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.350792049216754
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.14285699999999998	5.350792049216754
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.350792049216754
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14285699999999998	5.350792049216754
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.350792049216754
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	5.350792049216754
PACMAN DYSPLASIA	0.14285699999999998	5.350792049216754
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	5.350792049216754
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.14285699999999998	5.350792049216754
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.350792049216754
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	5.350792049216754
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	5.350792049216754
GANGLIONEUROMA	0.14285699999999998	5.350792049216754
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.140035704	5.245118766106463
49,XXXYY SYNDROME	0.1376736	5.156644786514121
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.152640934642017
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.13602788	5.095003386434062
CHRISTIANSON SYNDROME	0.1353348	5.06904367180005
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.962066784620787
SMITH-MAGENIS SYNDROME; SMS	0.132084993	4.947320259877015
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.131709139	4.93324242963512
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.13149785400000003	4.925328627034487
CENTRAL CONGENITAL HYPOTHYROIDISM	0.13095230000000002	4.9048945845611165
ADNP SYNDROME	0.130009449	4.86957955180531
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12522615399999998	4.690418454658804
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12231927000000001	4.581539423213407
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.425498720322556
TRISOMY 18P	0.11509595	4.310985770085114
WHITE-SUTTON SYNDROME; WHSUS	0.11370593400000001	4.258921912093668
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.111571194	4.178963983401724
2Q23.1 MICRODUPLICATION SYNDROME	0.11145755400000001	4.174707531085961
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.1114551	4.174615615088224
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.111069204	4.1601616558938925
CONGENITAL TRACHEAL STENOSIS	0.10927035000000002	4.092784532750458
FLYNN-AIRD SYNDROME	0.108538459	4.065371129531201
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.10817310000000001	4.051686395620298
KUFOR-RAKEB SYNDROME	0.1051948	3.9401324363450634
SECKEL SYNDROME 7; SCKL7	0.10490220900000002	3.9291732702105913
AICARDI SYNDROME; AIC	0.1036867	3.8836456734323335
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.10353536899999999	3.8779774827829425
WITTEVEEN-KOLK SYNDROME	0.10340361300000002	3.8730424851472898
MARINESCO-SJÖGREN SYNDROME	0.10156835400000001	3.8043017915484216
CORNEODERMATOOSSEOUS SYNDROME	0.10136164	3.796559198412196
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.10128821000000002	3.7938088350406143
KAPOSI SARCOMA	0.1	3.7455581800099087
NAGER SYNDROME	0.1	3.7455581800099087
METAPHYSEAL ANADYSPLASIA	0.1	3.7455581800099087
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	3.7455581800099087
AICARDI SYNDROME	0.09992303	3.7426752238787544
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.7063460812457123
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.6853990471240063
NEUROFIBROMATOSIS TYPE 1	0.09829781900000001	3.6818020003258347
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.675210979052052
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.675210979052052
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.675210979052052
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.675210979052052
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.675210979052052
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.09720319399999999	3.6408021840979
OROMANDIBULAR DYSTONIA	0.09684680000000001	3.6274532394778363
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.09554843300000002	3.578822148102787
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.094946573	3.5562791316405793
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.09484483300000002	3.5524684007482374
PEDIATRIC-ONSET GRAVES DISEASE	0.09456766400000001	3.5420868745962855
AARSKOG-SCOTT SYNDROME	0.094108154	3.524875660203322
CHOREOACANTHOCYTOSIS	0.09381280900000001	3.5138133413965718
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.09339324000000002	3.4980981403962863
CONGENITAL ANALBUMINEMIA	0.09283541000000001	3.477204293200737
PRADER-WILLI SYNDROME	0.09193923900000002	3.4436376870033607
TETRASOMY 9P	0.09147909300000003	3.4264026508603727
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.09145051900000001	3.4253323950660155
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09128212900000002	3.4190252496466975
BECKWITH-WIEDEMANN SYNDROME	0.09094444	3.406376911684203
POSTAXIAL TETRAMELIC OLIGODACTYLY	0.0909091	3.4050532314233877
RARE CIRCULATORY SYSTEM DISEASE	0.0909091	3.4050532314233877
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0909091	3.4050532314233877
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.0909091	3.4050532314233877
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.08997722	3.3701491238555112
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08992909	3.3683463867034726
ZECHI-CEIDE SYNDROME	0.08990853400000003	3.3675764497639906
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08973860000000002	3.3612114729263722
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08969697	3.359652197056034
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.08863413	3.3198429064956168
3P25.3 MICRODELETION SYNDROME	0.08841383	3.3115914418250543
DISTAL MONOSOMY 17Q	0.08806016	3.2983445262098137
3MC SYNDROME 2	0.087452294	3.275576551523314
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.08658005000000002	3.2429061450316694
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.08658005000000002	3.2429061450316694
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.08639310000000001	3.2359038240141405
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	3.2280104347055882
ERMINE PHENOTYPE	0.08605810000000001	3.2233562041111075
15Q13.3 MICRODELETION SYNDROME	0.085852493	3.2156550743039336
MONOSOMY 13Q34	0.08551017400000002	3.202833316997707
CONGENITAL ENTEROVIRUS INFECTION	0.08532646	3.1959522022428826
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.08502160900000001	3.184533830675541
ACROOTOOCULAR SYNDROME	0.08496462000000002	3.1823992745243355
3MC SYNDROME 3	0.08492067	3.1807531017042203
VELOCARDIOFACIAL SYNDROME	0.0840023	3.146355019046463
JOUBERT SYNDROME 26	0.08387885400000002	3.141731277295569
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.08387471900000001	3.1415763984648253
SECONDARY SHORT BOWEL SYNDROME	0.08333330000000001	3.1212972348221975
SCLEROSTEOSIS	0.08333330000000001	3.1212972348221975
POSTORGASMIC ILLNESS SYNDROME	0.08333330000000001	3.1212972348221975
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.08333330000000001	3.1212972348221975
MUCKLE-WELLS SYNDROME	0.08333330000000001	3.1212972348221975
ACUTE MONOBLASTIC LEUKEMIA	0.08333330000000001	3.1212972348221975
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	0.08333330000000001	3.1212972348221975
ALKAPTONURIA	0.08333330000000001	3.1212972348221975
POLYDACTYLY, PREAXIAL IV; PPD4	0.08333330000000001	3.1212972348221975
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	3.1212972348221975
DIPROSOPUS	0.08333330000000001	3.1212972348221975
MECKEL SYNDROME, TYPE 1; MKS1	0.08301180999999999	3.109255639829283
TURNPENNY-FRY SYNDROME; TPFS	0.08277251399999999	3.100292668926846
TRISOMY 8P	0.082238499	3.0802908264118667
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.08192708	3.0686264465832616
ETHYLMALONIC ENCEPHALOPATHY	0.081774859	3.062924920466069
8Q24.3 MICRODELETION SYNDROME	0.081398943	3.0488447679781028
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.081036494	3.0352690298102383
TRICHOHEPATOENTERIC SYNDROME 1	0.08098814000000001	3.033457902607877
KBG SYNDROME	0.080279573	3.006918113378526
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.08016985000000001	3.002808374576674
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.08012031300000001	3.000952937421043
DIENCEPHALIC SYNDROME	0.0798771	2.991843253004695
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0794169	2.974606194260289
SCLEROSTEOSIS 1; SOST1	0.07930664	2.9704763418110103
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.07908661	2.962234990147534
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07897228	2.9579526934803293
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07828091999999999	2.932057402447012
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07818681	2.9285324576438048
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07762181900000001	2.9073703910269857
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.901633506840574
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.901633506840574
N SYNDROME	0.07746865400000001	2.901633506840574
DDOST-CDG	0.07746451900000001	2.90147862800983
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07746451900000001	2.90147862800983
49,XYYYY SYNDROME	0.077381	2.898350375273467
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07704658	2.8858244796078782
PAPILLARY TUMOR OF THE PINEAL REGION	0.07692310000000001	2.881199464367202
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.881199464367202
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.881199464367202
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.881199464367202
DERMOODONTODYSPLASIA	0.07692310000000001	2.881199464367202
DERMATOMYOSITIS	0.07692310000000001	2.881199464367202
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.881199464367202
PINEOCYTOMA	0.07692310000000001	2.881199464367202
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.881199464367202
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.07692310000000001	2.881199464367202
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.881199464367202
MEIER-GORLIN SYNDROME 1; MGORS1	0.0765776	2.8682585608552675
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07628449400000001	2.857280105096168
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.076280359	2.8571252262654245
MOSAIC TRISOMY 15	0.0760649	2.849055084066357
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.07573894	2.8368460626227967
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07485824999999999	2.8038593062872668
SCALP-EAR-NIPPLE SYNDROME; SENS	0.07426292000000001	2.7815608747742147
3MC SYNDROME 1	0.07415340000000001	2.7774587394554677
KNIEST-LIKE DYSPLASIA, LETHAL	0.07372334999999999	2.761350966502335
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.07361754000000001	2.7573877913920666
XP22.13P22.2 DUPLICATION SYNDROME	0.07345811899999999	2.7514165850859125
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07300403999999999	2.7344087919577054
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.072970574	2.7331553034571834
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.0726316	2.7204588350720766
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.716112976282557
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.07251557300000001	2.716112976282557
BAKER-GORDON SYNDROME; BAGOS	0.07234092400000001	2.7095713963767514
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.072260429	2.706556409319752
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.072232369	2.705505405694441
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.695833812639929
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07197001900000001	2.6956789338091856
FRONTORHINY	0.0716529	2.68380105716432
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.071648993	2.6836547182062263
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.071600233	2.6818283840376536
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	2.6753997701665577
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.07142860000000001	2.6753997701665577
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.6753997701665577
GLUCAGONOMA	0.07142860000000001	2.6753997701665577
PPOMA	0.07142860000000001	2.6753997701665577
3MC SYNDROME	0.07142860000000001	2.6753997701665577
WEISMANN-NETTER SYNDROME	0.07142860000000001	2.6753997701665577
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.6753997701665577
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.07142860000000001	2.6753997701665577
GRFOMA	0.07142860000000001	2.6753997701665577
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07142860000000001	2.6753997701665577
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.07142860000000001	2.6753997701665577
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.07142860000000001	2.6753997701665577
MALT LYMPHOMA	0.07142860000000001	2.6753997701665577
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.071273159	2.6695776370759683
WOLF-HIRSCHHORN SYNDROME	0.070893733	2.6553660154958836
EMANUEL SYNDROME	0.070817583	2.6525137729418065
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07073174	2.6492984734333405
WIDOW'S PEAK SYNDROME	0.0707196	2.648843762670287
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.06946564400000001	2.601876111138562
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.06926376000000001	2.594314428462431
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.5737932643057926
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.5737932643057926
YOU-HOOVER-FONG SYNDROME; YHFS	0.06851795399999999	2.566379830822426
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.067767309	2.5382639856220908
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06749318	2.5279963244388117
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.5174740776660367
ATELOSTEOGENESIS TYPE II	0.06683839999999999	2.5034711585877423
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.4970400351926654
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.4970400351926654
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.4970400351926654
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.4970400351926654
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.4970400351926654
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.4970400351926654
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.4970400351926654
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.4970400351926654
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.4970400351926654
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.4970400351926654
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.065901773	2.468389249373061
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.065303813	2.445992309679874
9Q33.3Q34.11 MICRODELETION SYNDROME	0.065185229	2.441550676967691
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.06517233900000001	2.4410678745182883
BANGSTAD SYNDROME	0.064982899	2.4339722891020767
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4276760432570623
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4276760432570623
C SYNDROME	0.06450483900000001	2.416066273666722
ASCHER SYNDROME	0.06444148	2.413693125459449
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.064030564	2.3983020276084797
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.063748	2.3877184285927164
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.063658244	2.384356565392667
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06352411	2.379332498383492
HOLMES-GANG SYNDROME	0.063504124	2.3785839111256353
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.344638891185333
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.062504	2.341123684833393
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.06241946	2.3379571899480127
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.061868669	2.317326992592754
611961 STEVENSON-CAREY SYNDROME	0.061783093	2.314121693724629
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0616699	2.3098819840539306
HAMAMY SYNDROME; HMMS	0.06156176	2.305831537438068
PENILE AGENESIS	0.06132725	2.2970478289501264
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.06132725	2.2970478289501264
FANCONI ANEMIA	0.061216324	2.292893031083369
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	2.2860999369457757
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	2.2860999369457757
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.2742916902274763
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.060707613	2.273838964610259
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.06069612	2.27340848760863
17Q21.31 MICRODUPLICATION SYNDROME	0.060457274000000005	2.2644623717180035
RING CHROMOSOME 8 SYNDROME	0.06045482	2.264370455720266
1P36 DELETION SYNDROME	0.060176413	2.253942559558046
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	2.2486795633925687
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.059910473	2.2439816221341276
INCONTINENTIA PIGMENTI	0.059910473	2.2439816221341276
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.059885789	2.2430570685529743
POTOCKI-LUPSKI SYNDROME	0.059336553	2.2224851146274145
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.0588235	2.2032684160181284
ANOPHTHALMIA PLUS SYNDROME	0.0588235	2.2032684160181284
CRANIO-OSTEOARTHROPATHY	0.0588235	2.2032684160181284
VON WILLEBRAND DISEASE	0.0588235	2.2032684160181284
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.058821819000000004	2.2032054531851224
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.058745820000000004	2.200358866423897
AMISH INFANTILE EPILEPSY SYNDROME	0.058561190000000006	2.1934434423561444
DISTAL MONOSOMY 10Q	0.058182892999999986	2.179274108127912
15Q OVERGROWTH SYNDROME	0.057862459000000005	2.1672720662293794
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1641052342437628
CHIME SYNDROME	0.057728339000000004	2.1622485235983504
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.057507039	2.1539596033459882
LETHAL KNIEST-LIKE DYSPLASIA	0.05738348	2.1493316291143496
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.05694194	2.1327934915263342
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.056773114	2.1264700154733505
2P15P16.1 MICRODELETION SYNDROME	0.056773114	2.1264700154733505
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.05665564	2.1220699584569656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.05665484	2.1220399939915255
7P22.1 MICRODUPLICATION SYNDROME	0.056101154	2.101301362726956
CRYPTOCOCCOSIS	0.056097019000000005	2.1011464838962124
CROSSED POLYSYNDACTYLY	0.055555600000000004	2.080867320253585
GITELMAN SYNDROME	0.055555600000000004	2.080867320253585
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.080867320253585
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.080867320253585
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.080867320253585
WILDERVANCK SYNDROME	0.055555600000000004	2.080867320253585
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.080867320253585
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.080867320253585
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.080867320253585
ACROCRANIOFACIAL DYSOSTOSIS	0.055555600000000004	2.080867320253585
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.080867320253585
AGNATHIA-OTOCEPHALY COMPLEX	0.055555600000000004	2.080867320253585
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.080867320253585
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.080867320253585
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0553343	2.072578400001223
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.055226333999999995	2.0685344706565933
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.055222199	2.06837959182585
MOWAT-WILSON SYNDROME; MOWS	0.055137659	2.0652130969404694
2Q31.1 MICRODELETION SYNDROME	0.055111272999999995	2.0642247939590916
TARP SYNDROME	0.05478817300000001	2.0521228954794806
SILVER-RUSSELL SYNDROME; SRS	0.054593054	2.0448145998142264
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.05370222299999999	2.011448006423662
AXENFELD-RIEGER SYNDROME	0.05364868	2.0094425222073395
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.053288619	1.9959562279688143
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.05323698	1.994022059180239
BETA-THALASSEMIA MAJOR	0.05323698	1.994022059180239
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.053177154	1.9917812415434661
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.053173019	1.9916263627127229
8P11.2 DELETION SYNDROME	0.053039993	1.986643796488183
YUNIS-VARON SYNDROME	0.05284777	1.9794439721878225
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0527472	1.9756770643261863
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0527472	1.9756770643261863
OCULODENTODIGITAL DYSPLASIA; ODDD	0.052701808999999995	1.973976918012698
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	1.9713471990700948
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.0526316	1.9713471990700948
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	1.9713471990700948
STEINERT MYOTONIC DYSTROPHY	0.0526316	1.9713471990700948
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	1.9713471990700948
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0526316	1.9713471990700948
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.9713471990700948
PYGMY	0.0526316	1.9713471990700948
THREE M SYNDROME 2; 3M2	0.0526316	1.9713471990700948
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	1.9713471990700948
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0526316	1.9713471990700948
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	1.9713471990700948
BIEMOND SYNDROME II	0.0526316	1.9713471990700948
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	1.9713471990700948
274210 THYMIC APLASIA WITH FETAL DEATH	0.0526316	1.9713471990700948
MYASTHENIA GRAVIS; MG	0.0526316	1.9713471990700948
XQ12-Q13.3 DUPLICATION SYNDROME	0.05255728	1.9685635002307116
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.05232698999999999	1.9599378542979666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.052088174	1.9509928620747943
16Q24.3 MICRODELETION SYNDROME	0.052084239000000004	1.9508454743604111
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.9207677057853862
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9170185893251055
TRISOMY 20P	0.051169099999999995	1.9165684106874497
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.051066104	1.9127106355843673
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.050903768999999995	1.9066302837128477
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.050903768999999995	1.9066302837128477
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.050893029000000006	1.9062280107643153
TRISOMY 17P	0.050649353999999994	1.8971010218691755
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0503438	1.8856563190278282
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.049859850000000004	1.8675296902156704
PITT-HOPKINS-LIKE SYNDROME	0.049725129	1.8624836367799793
CRANIOFRONTONASAL DYSPLASIA	0.049523019999999994	1.8549135265979428
ERYTHERMALGIA, PRIMARY	0.0494995	1.8540325713140047
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.049484719	1.8534789403594174
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.83820211948852
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04907410999999999	1.83809934137206
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.048913293	1.8320758470737135
JOUBERT SYNDROME WITH RENAL DEFECT	0.048705973	1.8243105558549175
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.048705973	1.8243105558549175
JOUBERT SYNDROME	0.048705973	1.8243105558549175
JOUBERT SYNDROME WITH OCULAR DEFECT	0.048705973	1.8243105558549175
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.048705973	1.8243105558549175
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.048318150000000004	1.8097844197544577
ZELLWEGER SYNDROME	0.048255039000000007	1.8074205605314717
RING CHROMOSOME 1 SYNDROME	0.04816774	1.8041507256959046
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.048164554	1.8040313922122895
GRANULOMATOSIS WITH POLYANGIITIS	0.048160419	1.8038765133815464
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.048160419	1.8038765133815464
MICROHYDRANENCEPHALY; MHAC	0.047676260000000005	1.7857420563527922
MOSAIC TRISOMY 9	0.047658204	1.7850657583678093
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.047619	1.7835973497389184
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.047619	1.7835973497389184
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0475633	1.7815110738326527
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.04754470399999999	1.7808145498334977
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.047460554	1.7776626626250198
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.04707426	1.7631937961091322
DISTAL TRISOMY 18Q	0.046748654	1.7509980339415292
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.7494663253793958
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.046689294	1.748774670605875
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.046614453	1.745971457408374
HAND-FOOT-GENITAL SYNDROME	0.046203100000000004	1.730563991468158
8Q22.1 MICRODELETION SYNDROME	0.045988494000000005	1.7225257988803662
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.04597704	1.7220967826464275
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.7213349361126136
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.04592198399999999	1.720034628134841
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.045762488999999996	1.7140606501156346
LISSENCEPHALY, X-LINKED, 2	0.045627769000000006	1.7090146341355255
MOSAIC TRISOMY 1	0.04561545	1.7085532188233297
HALLERMANN-STREIFF SYNDROME; HSS	0.04550375	1.7043694303362587
FRASER SYNDROME	0.04544294	1.7020917564069946
OROFACIODIGITAL SYNDROME TYPE 2	0.04526674400000001	1.6954922327161448
BRADDOCK SYNDROME	0.04510962	1.6896070618813857
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.04510152	1.689303671668805
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.04497351	1.684508982642574
DISTAL MONOSOMY 12Q	0.044937054	1.6831435019524696
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.682711114716169
ALSTROM SYNDROME; ALMS	0.044625034	1.6714566113192029
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.664691234312142
ALLAN-HERNDON-DUDLEY SYNDROME	0.044444410000000004	1.664691234312142
PYRIDOXINE-DEPENDENT EPILEPSY	0.044297954	1.6592056396240265
PGM3-CDG	0.04425729899999999	1.657682882945943
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.044192229000000006	1.655245648238211
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.044025794	1.6490117284813115
ABLEPHARON MACROSTOMIA SYNDROME	0.044023854	1.6489390646526194
FAMILIAL THROMBOCYTOSIS	0.044019719000000006	1.648784185821876
LASSA FEVER	0.044019719000000006	1.648784185821876
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.648784185821876
KEUTEL SYNDROME; KTLS	0.044019719000000006	1.648784185821876
ATYPICAL WERNER SYNDROME	0.04377882	1.6397611736218138
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.043663129	1.6354278999077785
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.6285050221792483
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.6285050221792483
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.6285050221792483
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	1.6285050221792483
OCULOTRICHOANAL SYNDROME	0.043478300000000004	1.6285050221792483
ASHERMAN SYNDROME	0.043478300000000004	1.6285050221792483
RINGED HAIR DISEASE	0.043478300000000004	1.6285050221792483
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	1.6285050221792483
YELLOW FEVER	0.043478300000000004	1.6285050221792483
WERNER SYNDROME	0.043478300000000004	1.6285050221792483
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.043478300000000004	1.6285050221792483
PACHYDERMOPERIOSTOSIS	0.043478300000000004	1.6285050221792483
JOHANSON-BLIZZARD SYNDROME	0.043478300000000004	1.6285050221792483
HYDATIDIFORM MOLE	0.043478300000000004	1.6285050221792483
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.6285050221792483
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.6285050221792483
FRONTONASAL DYSPLASIA 1; FND1	0.04345879999999999	1.6277746383341458
FABRY DISEASE	0.04331325900000001	1.622323315503378
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.043266764	1.6205818182275824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.6199072431993624
CUTIS LAXA	0.043219494	1.6188112928758915
15Q26 OVERGROWTH SYNDROME	0.043200329999999995	1.6180934941062743
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.6151487362651509
HYPERTELORISM, TEEBI TYPE	0.04306176	1.6129032741362348
SECKEL SYNDROME	0.04304742	1.6123661610932216
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.04284385899999999	1.604741665406411
TEMPLE-BARAITSER SYNDROME	0.042794789	1.6029037200074803
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.042785209	1.6025448955338355
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.6014714560150265
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.6014714560150265
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.6014714560150265
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.5994732007259909
GORLIN SYNDROME	0.04268214	1.5986843861732811
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.04264079999999999	1.5971359724216645
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.042599213999999996	1.5955783445969258
COG2-CDG	0.04221225399999999	1.5810845326635594
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.5809296538328161
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.042063500000000004	1.575512865048468
3Q13 MICRODELETION SYNDROME	0.042057460000000005	1.5752866333343953
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.04182747999999999	1.566672598632008
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.04182747999999999	1.566672598632008
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.04178888	1.5652268131745246
HISTIDINEMIA	0.041666699999999994	1.5606504901901883
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.5606504901901883
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.5606504901901883
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5606504901901883
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.041575253000000006	1.557225289601315
MERRF	0.041517359999999996	1.5550568736041614
FILIPPI SYNDROME; FLPIS	0.04146710900000001	1.5531746931631252
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.04134734	1.548688675586509
CANAVAN DISEASE	0.04134734	1.548688675586509
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.5458350846314866
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.04126499	1.5456042084252708
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.041174899	1.542229797605318
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.04051068	1.517351088517638
OROFACIODIGITAL SYNDROME TYPE 6	0.040481773	1.5162683600145423
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.040464653999999996	1.5156271579097065
CHAR SYNDROME	0.040307354	1.509735394892551
PROTEUS SYNDROME	0.040303219	1.5095805160618077
16P13.11 MICRODELETION SYNDROME	0.040285254	1.5089076265347687
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.040048023	1.5000220014087497
SARCOSINEMIA	0.039845904	1.4924515166708954
ATYPICAL RETT SYNDROME	0.039834659	1.4920303286535532
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.03977934	1.4899583233239537
BRACHYDACTYLY, TYPE A3	0.0397618	1.4893013524191798
BRACHYDACTYLY, TYPE A1, D	0.0397618	1.4893013524191798
CLEIDORHIZOMELIC SYNDROME	0.0397618	1.4893013524191798
BRACHYDACTYLY, TYPE A2; BDA2	0.0397618	1.4893013524191798
CLEIDORHIZOMELIC SYNDROME	0.0397618	1.4893013524191798
SYNPOLYDACTYLY 1	0.0397618	1.4893013524191798
PIERPONT SYNDROME	0.039744383	1.4886489885509675
BRACHYDACTYLY TYPE A4	0.0397397	1.4884735840613978
ALPERS-HUTTENLOCHER SYNDROME	0.039675944000000005	1.4860855659881507
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.03961994	1.4839879035850176
CRANIOFRONTONASAL SYNDROME; CFNS	0.039542273999999995	1.481078878368931
DISTAL MONOSOMY 15Q	0.039503973000000005	1.4796442921304058
SLC39A8-CDG	0.039502469000000005	1.4795879589353784
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.039502469000000005	1.4795879589353784
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4709593540116714
OCULODENTODIGITAL DYSPLASIA	0.039204819	1.4684393050125788
CLEIDOCRANIAL DYSPLASIA; CCD	0.03908618	1.4639956122433966
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038925144	1.457963915172636
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.038850453	1.4551663203124048
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.038833334	1.454525118207569
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.038765913000000006	1.4519998254270245
9P13 MICRODELETION SYNDROME	0.03857886	1.4449936464845705
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03857886	1.4449936464845705
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03854502	1.4437261495964553
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4428377031961566
EPISODIC ATAXIA, TYPE 1; EA1	0.0384615	1.440597859404511
BLACKFAN-DIAMOND ANEMIA	0.0384615	1.440597859404511
WILSON DISEASE	0.0384615	1.440597859404511
MUCOLIPIDOSIS III GAMMA	0.0384615	1.440597859404511
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.440597859404511
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	1.440597859404511
MYCETOMA	0.0384615	1.440597859404511
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	1.440597859404511
245800 LAURENCE-MOON SYNDROME	0.0384615	1.440597859404511
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0384615	1.440597859404511
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0384615	1.440597859404511
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	1.440597859404511
TUBEROUS SCLEROSIS 2; TSC2	0.038417498999999994	1.4389497763497245
TUBEROUS SCLEROSIS-1	0.038417498999999994	1.4389497763497245
MOEBIUS SYNDROME; MBS	0.03839377	1.4380609928491903
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.03837959	1.4375298726992647
HELSMOORTEL-VAN DER AA SYNDROME	0.038366653	1.4370453098375169
20Q11.2 MICRODELETION SYNDROME	0.038309034000000006	1.4348871566697774
HYPERTELORISM, TEEBI TYPE; TBHS	0.03828778	1.4340910757341978
WIEACKER-WOLFF SYNDROME	0.038286423	1.4340402485096948
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4189395437844214
HAREL-YOON SYNDROME; HAYOS	0.037821174	1.4166140765327806
MEIER-GORLIN SYNDROME 5; MGORS5	0.03781366	1.4163326352911347
GRANGE SYNDROME; GRNG	0.03776348	1.4144531141964058
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.037582554	1.407676425603641
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.407676425603641
LISSENCEPHALY 2; LIS2	0.037582554	1.407676425603641
JAWAD SYNDROME	0.037582554	1.407676425603641
HYPERTRICHOSIS CUBITI	0.037582554	1.407676425603641
HYPOPARATHYROIDISM, X-LINKED	0.037578419	1.4075215467728976
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.037470994	1.4034978808980219
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.037470994	1.4034978808980219
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.037136169999999996	1.3909568531773855
NEURONAL CEROID LIPOFUSCINOSIS	0.037109859	1.3899713593646434
KIKUCHI-FUJIMOTO DISEASE	0.037037	1.3872423831302698
PAROTIDOMEGALY, HEREDITARY BILATERAL	0.037037	1.3872423831302698
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.037037	1.3872423831302698
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.037037	1.3872423831302698
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.037037	1.3872423831302698
FIBROSCLEROSIS, MULTIFOCAL	0.037037	1.3872423831302698
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3872423831302698
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3872423831302698
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.037037	1.3872423831302698
BRACHYDACTYLY, TYPE A4	0.037037	1.3872423831302698
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3872423831302698
CERVICAL VERTEBRAE, AGENESIS OF	0.037037	1.3872423831302698
BRANCHIAL CLEFT ANOMALIESBRANCHIAL CYSTS, INCLUDED	0.037037	1.3872423831302698
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.037037	1.3872423831302698
CARCINOMA OF ESOPHAGUS	0.037037	1.3872423831302698
KAPOSIFORM LYMPHANGIOMATOSIS	0.037037	1.3872423831302698
MCLEOD SYNDROME; MCLDS	0.037037	1.3872423831302698
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.037037	1.3872423831302698
MYOCLONUS AND ATAXIA	0.037037	1.3872423831302698
MALAKOPLAKIA	0.037037	1.3872423831302698
DIABETIC EMBRYOPATHY	0.037037	1.3872423831302698
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.037037	1.3872423831302698
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.037032079999999995	1.3870581016678132
DIGITOTALAR DYSMORPHISM	0.0369623	1.3844444511698022
FRONTONASAL DYSPLASIA	0.03694754	1.383891606782433
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.03694754	1.383891606782433
COG1-CDG	0.03692544	1.3830638384246505
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.036868693999999994	1.380938383979822
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.03680556	1.3785736632784549
XP21 MICRODELETION SYNDROME	0.036801273	1.3784130911992778
PITT-HOPKINS SYNDROME	0.036801273	1.3784130911992778
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036801273	1.3784130911992778
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036765933	1.3770894109384624
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.03663744	1.3722766308662222
HUNTINGTON DISEASE	0.03656844	1.3696921957220154
WEST SYNDROME	0.03656844	1.3696921957220154
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.036484994	1.3665666772431242
LUSCAN-LUMISH SYNDROME; LLS	0.036402013	1.3634585756097701
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.036259854	1.35813392755665
47,XYY SYNDROME	0.036255719000000006	1.3579790487259067
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.036255719000000006	1.3579790487259067
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.036255719000000006	1.3579790487259067
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.036255719000000006	1.3579790487259067
THUMBS, CONGENITAL CLASPED	0.0361093	1.3524948398943177
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.036054333	1.3504360189295117
15Q24 MICRODELETION SYNDROME	0.035932933	1.3458889112989798
CORNELIA DE LANGE SYNDROME	0.035863098999999996	1.3432732381995514
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.035714300000000004	1.3376998850832789
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.035714300000000004	1.3376998850832789
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3359001443777838
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3359001443777838
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3359001443777838
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.03564196	1.3349903482958594
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.03561751	1.3340745593208472
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.035528454	1.3307389150280575
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.035524319	1.330584036197314
SLC35A2-CDG	0.035506354	1.329911146670275
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.03550485	1.329854813475248
OKAMOTO SYNDROME	0.035399363999999996	1.3259037739734825
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.035394252999999994	1.325712338494902
RAMOS-ARROYO SYNDROME	0.03531504	1.3227453694937712
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0349829	1.3103048725546862
SECKEL SYNDROME 2; SCKL2	0.0349829	1.3103048725546862
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0349829	1.3103048725546862
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0349829	1.3103048725546862
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3042052310585404
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3042052310585404
SWEENEY-COX SYNDROME; SWCOS	0.034768294	1.302266679966894
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.034764158999999996	1.3021118011361505
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.034520353999999996	1.2929799430153774
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.03443497399999999	1.2897819854412849
PEHO SYNDROME	0.03443497399999999	1.2897819854412849
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03443441	1.2897608604931499
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.03422274	1.281832637493523
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03422274	1.281832637493523
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.03407914	1.2764540159470288
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2760835802430255
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0339527	1.2717181321842244
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.033844733999999994	1.2676742028395944
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.033760194	1.2645077079542144
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.033426873999999995	1.2520230134286052
COCKAYNE SYNDROME	0.033345619	1.2489795601294382
DONNAI-BARROW SYNDROME	0.033345072999999996	1.2489591093817751
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.2489591093817751
DESMOSTEROLOSIS	0.033319659999999994	1.2480072506814892
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.03329918	1.2472401603662233
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	1.241787376767765
NOONAN SYNDROME 4; NS4	0.03288132	1.231588970955234
OROFACIAL CLEFT 15	0.03288132	1.231588970955234
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.2286799457391473
HYDROXYKYNURENINURIA	0.032803653999999995	1.2286799457391473
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	1.2286799457391473
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2286799457391473
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.2286799457391473
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.228525066908404
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.032799519	1.228525066908404
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.032799519	1.228525066908404
LEIGH SYNDROME	0.032799519	1.228525066908404
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.228525066908404
DEND SYNDROME	0.032799519	1.228525066908404
ISOLATED CEREBELLAR AGENESIS	0.032799519	1.228525066908404
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.228525066908404
SANDHOFF DISEASE	0.032799519	1.228525066908404
ISOTRETINOIN-LIKE SYNDROME	0.0322581	1.2082459032657762
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.2082459032657762
SPINOCEREBELLAR ATAXIA TYPE 34	0.0322581	1.2082459032657762
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2082459032657762
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2082459032657762
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.2082459032657762
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.2082459032657762
ALG13-CDG	0.0322581	1.2082459032657762
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2082459032657762
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.2082459032657762
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.2082459032657762
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.2082459032657762
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2082459032657762
DESMOID TUMOR	0.0322581	1.2082459032657762
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2082459032657762
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.2082459032657762
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2082459032657762
WIDOW'S PEAK	0.0322581	1.2082459032657762
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0322581	1.2082459032657762
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.2082459032657762
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.2082459032657762
MILD CANAVAN DISEASE	0.0322581	1.2082459032657762
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2082459032657762
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.2082459032657762
DENT DISEASE	0.0322581	1.2082459032657762
DYSTONIA, JUVENILE-ONSET	0.0322581	1.2082459032657762
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.2082459032657762
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.2082459032657762
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.2082459032657762
LESCH-NYHAN SYNDROME	0.0322581	1.2082459032657762
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0322581	1.2082459032657762
THROMBOCYTOPENIA 1	0.0322581	1.2082459032657762
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0322581	1.2082459032657762
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2082459032657762
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2082459032657762
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2082459032657762
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2082459032657762
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03208814	1.2018799525830315
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.031795554	1.1909209737264674
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.031795554	1.1909209737264674
AL KAISSI SYNDROME; ALKAS	0.031688503	1.1869113162391853
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.031570104	1.1824766128096353
AASE-SMITH SYNDROME	0.03147251	1.1788211727594364
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.03137644	1.1752228150159008
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.169622081869332
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.030815169	1.1542000831633774
CRANIOFACIOFRONTODIGITAL SYNDROME	0.030543479999999998	1.1440238135996903
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.030498773	1.1423492869041534
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.030255092999999997	1.1332221107311051
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.030209064	1.1314980677564286
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.1220701232615256
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.029953219	1.121915244430782
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.02983628	1.1175352261506601
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1128417795620353
48,XXYY SYNDROME	0.029636613	1.1100565824993798
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.02962456	1.1096051303719434
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.029583938999999997	1.1080836471836415
19P13.3 MICRODUPLICATION SYNDROME	0.029495554	1.1047731355862396
MIETENS SYNDROME	0.029428513999999996	1.102262113382361
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	1.1016360807881542
DARWINIAN POINT OF PINNA	0.0294118	1.1016360807881542
EAR FOLDING	0.0294118	1.1016360807881542
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	1.1016360807881542
OTOONYCHOPERONEAL SYNDROME	0.0294118	1.1016360807881542
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0294118	1.1016360807881542
DARWINIAN TUBERCLE OF PINNA	0.0294118	1.1016360807881542
AREDYLD	0.0294118	1.1016360807881542
OSTEOMA OF MIDDLE EAR	0.0294118	1.1016360807881542
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	1.1016360807881542
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0294118	1.1016360807881542
EAR WAX, WET/DRY	0.0294118	1.1016360807881542
HAIRY EARS, Y-LINKED	0.0294118	1.1016360807881542
MUSICAL PERFECT PITCH	0.0294118	1.1016360807881542
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	1.1016360807881542
ALKAPTONURIA	0.0294118	1.1016360807881542
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	1.1016360807881542
EAR WITHOUT HELIX	0.0294118	1.1016360807881542
OSSIFIED EAR CARTILAGES	0.0294118	1.1016360807881542
BLAU SYNDROME	0.0294118	1.1016360807881542
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	1.1016360807881542
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	1.1016360807881542
EAR MALFORMATION	0.0294118	1.1016360807881542
JACOBSEN SYNDROME	0.029215292999999996	1.094275796775362
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.02920324	1.0938243446479254
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.028856204	1.0808259093623465
CHROMOSOME 17Q12 DELETION SYNDROME	0.028658319999999998	1.0734140490134154
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0721285734460362
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0721285734460362
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.028593013	1.0709679373327965
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.028529854	1.0686022802418842
CARTILAGE-HAIR HYPOPLASIA	0.028494299999999997	1.067270584486563
PETERS-PLUS SYNDROME; PTRPLS	0.028444492999999998	1.0654050343238457
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	1.0615422776283834
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341364	1.0615422776283834
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0608677026001636
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0608677026001636
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	1.0608677026001636
MENKES DISEASE	0.028319219000000003	1.0607128237694203
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.028207339999999997	1.0565223307332068
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.028064520000000003	1.0511729245405168
VAN BOGAERT-HOZAY SYNDROME	0.02793651	1.046378235514286
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02793651	1.046378235514286
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.0404336601267925
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0404336601267925
OROFACIAL CLEFT 3	0.027777800000000002	1.0404336601267925
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0404336601267925
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0404336601267925
GANGLIOCYTOMA	0.027777800000000002	1.0404336601267925
DIMPLES, FACIAL	0.027777800000000002	1.0404336601267925
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0404336601267925
DWARFISM, LEVI TYPE	0.027777800000000002	1.0404336601267925
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0404336601267925
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.0404336601267925
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0404336601267925
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0404336601267925
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0404336601267925
CLEFT CHIN	0.027777800000000002	1.0404336601267925
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0404336601267925
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0404336601267925
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0404336601267925
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0404336601267925
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0404336601267925
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0404336601267925
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0404336601267925
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0404336601267925
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0404336601267925
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0404336601267925
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.0404336601267925
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0404336601267925
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0404336601267925
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0404336601267925
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0327460517846492
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.027535599	1.0313618807592266
AYMÉ-GRIPP SYNDROME	0.027495253999999997	1.0298507353115014
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.027442294	1.0278670876993683
SECKEL SYNDROME 1; SCKL1	0.027331729	1.0237258112976404
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.027238599999999998	1.020237610420179
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.02721415	1.0193218214451665
ADAMS-OLIVER SYNDROME	0.027122959000000002	1.0159062094852338
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0123120093112778
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0123120093112778
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0123120093112778
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0123120093112778
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.02692186	1.0083739294408156
RENPENNING SYNDROME 1; RENS1	0.026862179	1.006138542863404
TRISOMY 13	0.026467328999999998	0.9913492063896346
CONGENITAL HYPOTHYROIDISM	0.026163534000000002	0.9799703879166736
COFS SYNDROME	0.026042469	0.9754358279060447
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02602968	0.974956808470403
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.02599518	0.9736645908982997
6Q25 MICRODELETION SYNDROME	0.025870543	0.9689962395494807
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.025664603999999997	0.9612826744891501
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.025630312999999995	0.9599982851336428
COFFIN-SIRIS SYNDROME	0.025516233	0.9557253523618876
INFANTILE SIALIC ACID STORAGE DISEASE	0.025407353	0.9516471886154929
3C SYNDROME	0.025392673999999997	0.9510973781302491
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.025189419999999997	0.9434843813070517
MUCOPOLYSACCHARIDOSIS TYPE 1	0.02514364	0.9417696647722432
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.02491185	0.9330878354667983
MULTIPLE METAPHYSEAL DYSPLASIA	0.02484712	0.930663335656878
MECKEL SYNDROME	0.024824649999999997	0.9298217087338295
TERMINAL TRANSVERSE LIMB DEFECT	0.024824649999999997	0.9298217087338295
AICARDI-GOUTIÈRES SYNDROME	0.024788342999999997	0.9284618089254135
9Q21.13 MICRODELETION SYNDROME	0.024734938999999997	0.9264615310349609
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9262845534109556
COHEN SYNDROME	0.024645073	0.9230955477209134
RING CHROMOSOME 7 SYNDROME	0.024254469999999997	0.9084652851030491
HOLOPROSENCEPHALY	0.024143223	0.9042984639945335
ISOLATED SPINA BIFIDA	0.024077419	0.9018337368897598
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02406504	0.9013700742426565
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.023898752999999995	0.8951416979118632
PENTASOMY X	0.023825814	0.8924097252309461
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.0235581	0.8823823416049141
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.0235581	0.8823823416049141
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0235581	0.8823823416049141
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.023535999999999998	0.8815545732471319
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.023395153999999998	0.8762791043729151
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.023392444	0.8761775997462369
SALT-AND-PEPPER SYNDROME	0.023392444	0.8761775997462369
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.023212049999999998	0.8694208375229899
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.02320794	0.8692668950817914
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.02314531	0.8669210519936512
CHARGE SYNDROME	0.023079853999999997	0.8644693594313438
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.022989919999999997	0.8611008291377339
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.02288248	0.8570766014291313
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.02288248	0.8570766014291313
SHELDON-HALL SYNDROME	0.02279794	0.8539101065437508
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.022601589999999998	0.8465557030573013
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8432451540043179
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8432451540043179
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8432451540043179
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8432451540043179
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.022492253999999996	0.8424604595656057
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.022492253999999996	0.8424604595656057
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.022406893999999997	0.8392632511031493
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.022402593	0.8391021546458272
KNOBLOCH SYNDROME	0.022172739	0.8304928393467472
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.021995564000000002	0.8238566466413146
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8228111115309467
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.02183418	0.8178119150280876
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.02176525	0.8152301017746065
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02163132	0.8102136757041193
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.021526313	0.8062805774260362
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.021463814	0.803939641019112
QAZI-MARKOUIZOS SYNDROME	0.021462329	0.8038840194801387
ZUNICH NEUROECTODERMAL SYNDROME	0.021453518999999997	0.8035540358044798
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.021401394	0.8016016636031498
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.021378854	0.8007574147893755
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.021374719	0.8006025359586321
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7972946462519562
6Q TERMINAL DELETION SYNDROME	0.021233872999999997	0.7953270670844153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.021228263999999997	0.7951169787260984
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.0212212	0.7948523924962626
ATELOSTEOGENESIS, TYPE II	0.0212212	0.7948523924962626
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.021181103	0.7933505360328241
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.021164049999999997	0.7927118059963869
OHDO SYNDROME	0.021147878999999998	0.7921061117830976
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.021101304	0.790361618060758
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.021045054	0.7882547415845025
ACROCALLOSAL SYNDROME; ACLS	0.020912909	0.7833051737275283
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.020910783000000002	0.7832255431606214
COOPER-JABS SYNDROME	0.0208333	0.7803233723160042
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.0208333	0.7803233723160042
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.0208333	0.7803233723160042
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0208333	0.7803233723160042
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.0208333	0.7803233723160042
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.0208333	0.7803233723160042
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0208333	0.7803233723160042
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.0208333	0.7803233723160042
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.0208333	0.7803233723160042
HEREDITARY ACROKERATOTIC POIKILODERMA	0.0208333	0.7803233723160042
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.0208333	0.7803233723160042
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.0208333	0.7803233723160042
PSEUDOACHONDROPLASIA	0.0208333	0.7803233723160042
SATOYOSHI SYNDROME	0.0208333	0.7803233723160042
PROLIDASE DEFICIENCY	0.0208333	0.7803233723160042
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0208333	0.7803233723160042
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.7802949060738361
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.776860603778585
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.776860603778585
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.776860603778585
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0206972	0.7752256676330107
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.020691032999999998	0.7749946790600495
X SMALL RINGS	0.020639574	0.7730672522761983
GAUCHER DISEASE	0.020611849999999998	0.7720288337263722
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.020606022999999998	0.771810580051223
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.02056768	0.770374420678262
PYCNODYSOSTOSIS	0.02056768	0.770374420678262
HYPOCHONDROPLASIA	0.02056768	0.770374420678262
HYPOCHONDROPLASIA	0.02056768	0.770374420678262
JEUNE SYNDROME	0.02056768	0.770374420678262
AREDYLD SYNDROME	0.02056768	0.770374420678262
SHORT RIB-POLYDACTYLY SYNDROME	0.02056768	0.770374420678262
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.020545554	0.7695456784753529
COFFIN-LOWRY SYNDROME; CLS	0.020541419	0.7693907996446095
NEVUS COMEDONICUS SYNDROME	0.020541419	0.7693907996446095
GYRATE ATROPHY OF CHOROID AND RETINA	0.020541419	0.7693907996446095
JOUBERT SYNDROME 1	0.020527614	0.7688737253378591
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.767810211548227
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.02048314	0.7672079257928816
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.02042745	0.765122024442434
COFFIN-SIRIS SYNDROME 6; CSS6	0.020307914	0.7606447340163773
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.020220909	0.7573859111218597
MELAS	0.02021732	0.7572514830387792
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.020150623	0.754753308099458
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.020088733999999997	0.7524352195974315
FG SYNDROME TYPE 1	0.020016633	0.7497346346940627
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	0.7491116360019817
DISSECTING CELLULITIS OF THE SCALP	0.02	0.7491116360019817
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	0.7491116360019817
DARIER DISEASE	0.02	0.7491116360019817
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.7491116360019817
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	0.7491116360019817
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.7491116360019817
611426 TENTED EYEBROWS	0.02	0.7491116360019817
RINGED HAIR	0.02	0.7491116360019817
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	0.7491116360019817
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.7491116360019817
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.7491116360019817
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	0.7491116360019817
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.7491116360019817
FAMILIAL MELANOMA	0.02	0.7491116360019817
HAIRY NOSE TIP	0.02	0.7491116360019817
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02	0.7491116360019817
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	0.7491116360019817
CATATRICHY	0.02	0.7491116360019817
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	0.7491116360019817
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.7491116360019817
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.7491116360019817
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02	0.7491116360019817
WERNER SYNDROME; WRN	0.02	0.7491116360019817
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.7491116360019817
HAIR WHORL	0.02	0.7491116360019817
MIDPHALANGEAL HAIR	0.02	0.7491116360019817
BAND HETEROTOPIA; BH	0.019954873	0.7474213779620886
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	0.7474213779620886
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.019871532999999997	0.7442998297748683
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.019724959999999996	0.7388098527836823
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.019705188999999998	0.7380693184759126
16P13.2 MICRODELETION SYNDROME	0.019677793	0.7370431853569172
KEIPERT SYNDROME; KPTS	0.019606290000000002	0.7343649988914647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019596943999999998	0.7340149390239609
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.019548259999999998	0.7321914514796048
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.019548259999999998	0.7321914514796048
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.019548259999999998	0.7321914514796048
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7269873354887174
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7269873354887174
HHHH SYNDROME	0.019409319	0.7269873354887174
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01933486	0.7241984303234636
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.7225398971613555
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.019275884	0.7219894499312212
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.019222759	0.7199996221480909
MUENKE SYNDROME	0.019218013	0.7198218579568675
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.719373402275975
BOHRING-OPITZ SYNDROME	0.019180613	0.7184210191975439
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.019137459	0.7168046610205423
ACERULOPLASMINEMIA	0.01913148	0.7165807140969596
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7147313072899979
HARROD SYNDROME	0.019059919	0.7139003552077628
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.018933593999999998	0.7091687788368651
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.018910813	0.7083155032278771
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.018896294	0.7077716856357216
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7067081718460895
MONOPHALANGY OF GREAT TOE	0.0188679	0.7067081718460895
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7067081718460895
KNUCKLE PADS	0.0188679	0.7067081718460895
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7067081718460895
SPINAL ARACHNOIDITIS	0.0188679	0.7067081718460895
RAYNAUD DISEASE	0.0188679	0.7067081718460895
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7067081718460895
PUBIC BONE DYSPLASIA	0.0188679	0.7067081718460895
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7067081718460895
TOE, MISSHAPEN	0.0188679	0.7067081718460895
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7067081718460895
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7067081718460895
VESICOURETERAL REFLUX 1	0.0188679	0.7067081718460895
TRACHEOBRONCHOMEGALY	0.0188679	0.7067081718460895
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7067081718460895
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7067081718460895
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7067081718460895
VAN DEN BOSCH SYNDROME	0.0188679	0.7067081718460895
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7067081718460895
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7067081718460895
NEPHROSIALIDOSIS	0.0188679	0.7067081718460895
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7067081718460895
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7067081718460895
THROMBOCYTOPENIA 3	0.0188679	0.7067081718460895
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7067081718460895
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7067081718460895
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7067081718460895
LETTERER-SIWE DISEASE	0.0188679	0.7067081718460895
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7067081718460895
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.7067081718460895
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7067081718460895
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7067081718460895
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7067081718460895
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7067081718460895
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7067081718460895
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7067081718460895
CARPAL DISPLACEMENT	0.0188679	0.7067081718460895
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7067081718460895
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7067081718460895
GORDON SYNDROME	0.018853799999999997	0.706180048142708
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.018853799999999997	0.706180048142708
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.018853799999999997	0.706180048142708
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.018853799999999997	0.706180048142708
LATHOSTEROLOSIS	0.018847292999999998	0.7059363246719348
10Q22.3Q23.3 MICRODELETION SYNDROME	0.018847292999999998	0.7059363246719348
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.018739014000000002	0.701880671730202
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.018620429	0.6974390015624372
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.018540523	0.6944460758431185
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6942972648166267
THORACOMELIC DYSPLASIA	0.0185185	0.6936211915651349
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0185185	0.6936211915651349
ISOLATED EPISPADIAS	0.0185185	0.6936211915651349
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.0185185	0.6936211915651349
OSTEOPATHIA STRIATA-PIGMENTARY DERMOPATHY-WHITE FORELOCK SYNDROME	0.0185185	0.6936211915651349
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.0185185	0.6936211915651349
EXSTROPHY OF BLADDER	0.0185185	0.6936211915651349
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0185185	0.6936211915651349
ELLIS VAN CREVELD SYNDROME	0.0185185	0.6936211915651349
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0185185	0.6936211915651349
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0185185	0.6936211915651349
OSTEOGENESIS IMPERFECTA, TYPE V	0.0185185	0.6936211915651349
OSTEOARTHRITIS	0.0185185	0.6936211915651349
GAPO SYNDROME	0.0185185	0.6936211915651349
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0185185	0.6936211915651349
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0185185	0.6936211915651349
GRANT SYNDROME	0.0185185	0.6936211915651349
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.0185185	0.6936211915651349
CARTILAGE-HAIR HYPOPLASIA; CHH	0.0185185	0.6936211915651349
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0185185	0.6936211915651349
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.0185185	0.6936211915651349
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.0185185	0.6936211915651349
CAMURATI-ENGELMANN DISEASE	0.0185185	0.6936211915651349
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.0185185	0.6936211915651349
FOUNTAIN SYNDROME	0.018507619	0.693213637379568
HENNEKAM SYNDROME	0.018423079	0.6900471424941876
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.01835074	0.6873376431623504
DUANE RETRACTION SYNDROME	0.018329793	0.6865530610903836
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.018260528999999998	0.6839587376725814
FACIOCARDIORENAL SYNDROME	0.0180465	0.6759421569554881
TEMPLE SYNDROME	0.01802396	0.6750979081417139
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018008939999999998	0.6745353253030762
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.01793371	0.6717175418842549
ACRO-RENAL-OCULAR SYNDROME	0.017760319999999996	0.6652231185559356
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01769641	0.6628293323230914
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.017644564	0.6608874102290835
RUBINSTEIN-TAYBI SYNDROME	0.017521433	0.6562754669864554
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.017490903999999998	0.6551319855296802
SAETHRE-CHOTZEN SYNDROME	0.017473019	0.6544620924491855
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.017365939	0.650451348750031
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.017363392999999998	0.6503559868387677
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6457866680482284
SICKLE CELL ANEMIA	0.0172414	0.6457866680482284
MOTION SICKNESS	0.0172414	0.6457866680482284
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6457866680482284
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6457866680482284
CARDIAC ARRHYTHMIA	0.0172414	0.6457866680482284
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6457866680482284
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6457866680482284
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6457866680482284
RHEUMATOID ARTHRITIS	0.0172414	0.6457866680482284
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6457866680482284
CERVICAL RIB	0.0172414	0.6457866680482284
269800 SENILE PLAQUE FORMATION	0.0172414	0.6457866680482284
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6457866680482284
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6457866680482284
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6457866680482284
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6457866680482284
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6457866680482284
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6457866680482284
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6457866680482284
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6457866680482284
PALMOMENTAL REFLEX	0.0172414	0.6457866680482284
TRANSSEXUALITY	0.0172414	0.6457866680482284
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6457866680482284
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6457866680482284
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6457866680482284
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6457866680482284
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6457866680482284
ALCOHOL DEPENDENCE	0.0172414	0.6457866680482284
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6457866680482284
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6457866680482284
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6457866680482284
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6457866680482284
DIASTEMATOMYELIA	0.0172414	0.6457866680482284
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6457866680482284
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6457866680482284
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6457866680482284
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6457866680482284
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6457866680482284
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6457866680482284
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6457866680482284
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6457866680482284
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6457866680482284
MYOPATHY, CONGENITAL	0.0172414	0.6457866680482284
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6457866680482284
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6457866680482284
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6457866680482284
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.017168832999999998	0.6430686288437405
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.017102273999999997	0.6405756227747077
INDOMETHACIN EMBRYOFETOPATHY	0.017099009999999998	0.6404533677557122
RENAL TUBULAR DYSGENESIS	0.017099009999999998	0.6404533677557122
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.017090773	0.6401448461284248
STÜVE-WIEDEMANN SYNDROME	0.01701633	0.63735654025248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.01701633	0.63735654025248
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.016931599999999998	0.6341829288065576
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.016931599999999998	0.6341829288065576
SUMMITT SYNDROME	0.016931599999999998	0.6341829288065576
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.016897743	0.6329147951735516
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016891613	0.6326851924571171
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6310165837435046
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6310165837435046
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.016674553999999998	0.6245551213271693
MARDEN-WALKER SYNDROME	0.016674553999999998	0.6245551213271693
GERODERMA OSTEODYSPLASTICA	0.016674553999999998	0.6245551213271693
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.016674553999999998	0.6245551213271693
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.016674553999999998	0.6245551213271693
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.016670419	0.6244002424964259
OCULOCEREBROCUTANEOUS SYNDROME	0.016670419	0.6244002424964259
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.016670419	0.6244002424964259
LINEAR VERRUCOUS NEVUS SYNDROME	0.016670419	0.6244002424964259
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.016661620000000002	0.6240706708321669
FONTAINE PROGEROID SYNDROME; FPS	0.01663216	0.622967229392336
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.016555979999999998	0.6201138631708044
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.016525674	0.6189787343087706
PELIZAEUS-MERZBACHER DISEASE	0.016501869	0.6180871041840192
CORNELIA DE LANGE SYNDROME 3	0.016387253	0.6137940952204191
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.016350194	0.6124060288144892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.016350194	0.6124060288144892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.016350194	0.6124060288144892
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.01633488	0.6118324340348026
DOWN SYNDROME	0.01633362	0.6117852400017344
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6105825412701331
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6105825412701331
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.016280613	0.6097998319772565
GABRIELE-DE VRIES SYNDROME	0.01627214	0.6094824708326644
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.016250340000000002	0.6086659391494222
NEUROFACIODIGITORENAL SYNDROME	0.01622266	0.6076291686451953
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0162162	0.6073872055867667
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0162162	0.6073872055867667
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0162162	0.6073872055867667
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.016210363	0.6071685773557994
NEMALINE MYOPATHY 2; NEM2	0.016128999999999998	0.6041210788537981
BARTSOCAS-PAPAS SYNDROME	0.016128999999999998	0.6041210788537981
PENTALOGY OF CANTRELL	0.016128999999999998	0.6041210788537981
STUVE-WIEDEMANN SYNDROME	0.016128999999999998	0.6041210788537981
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.016128999999999998	0.6041210788537981
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.016128999999999998	0.6041210788537981
KUSKOKWIM SYNDROME	0.016128999999999998	0.6041210788537981
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.016128999999999998	0.6041210788537981
ANTLEY-BIXLER SYNDROME	0.016128999999999998	0.6041210788537981
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.016128999999999998	0.6041210788537981
ACALVARIA	0.016128999999999998	0.6041210788537981
PHOCOMELIA, SCHINZEL TYPE	0.016128999999999998	0.6041210788537981
LAURIN-SANDROW SYNDROME	0.016128999999999998	0.6041210788537981
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.016128999999999998	0.6041210788537981
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.016128999999999998	0.6041210788537981
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.016125574	0.603992756030551
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01591702	0.5961812446238131
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01580464	0.5919719863411179
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01580464	0.5919719863411179
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01580464	0.5919719863411179
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.015779999	0.5910490433499817
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.015678313	0.5872403350590569
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01566324	0.5866757670745839
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01566324	0.5866757670745839
PERLMAN SYNDROME	0.015635813999999998	0.5856485102881344
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.015635813999999998	0.5856485102881344
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.015553568999999998	0.5825679759629853
21Q22.11Q22.12 MICRODELETION SYNDROME	0.015553568999999998	0.5825679759629853
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.015541250000000001	0.58210656065079
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.015505919	0.5807832174902106
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.57947358307257
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.57947358307257
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.57947358307257
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.57947358307257
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.57947358307257
MUCOPOLYSACCHARIDOSIS TYPE 2	0.015426473	0.5778075213385199
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.015423839	0.5777088633360584
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.015405873999999998	0.5770359738090196
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.015378059	0.5759941468012498
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.015372673	0.5757924110376746
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01534392	0.5747154506941764
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.015286603999999999	0.5725686465677218
BETA-UREIDOPROPIONASE DEFICIENCY	0.015286603999999999	0.5725686465677218
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.015286603999999999	0.5725686465677218
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.015286603999999999	0.5725686465677218
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.015286603999999999	0.5725686465677218
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.015249803999999999	0.5711902811574782
SILVER-RUSSELL SYNDROME	0.0151932	0.5690701454052655
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.015181173	0.5686196671229555
MALAN OVERGROWTH SYNDROME	0.015132758999999999	0.5668062925856855
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.01512334	0.5664534984607105
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01510677	0.5658328594702828
HEART AND BRAIN MALFORMATION SYNDROME	0.015053163000000001	0.5638249780967249
TETRASOMY X	0.015015374000000001	0.562409569116081
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5590395405991988
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5590395405991988
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5590395405991988
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5590395405991988
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.014884089999999997	0.5574922505150366
FRANK-TER HAAR SYNDROME; FTHS	0.01483226	0.5555509277103376
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.014831254	0.5555132473950467
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.014831254	0.5555132473950467
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.014831254	0.5555132473950467
DEXTROCARDIA	0.014831254	0.5555132473950467
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.014831254	0.5555132473950467
JOUBERT SYNDROME 2	0.014831254	0.5555132473950467
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.014831254	0.5555132473950467
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.014831254	0.5555132473950467
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014831254	0.5555132473950467
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.014831254	0.5555132473950467
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.014831254	0.5555132473950467
PFEIFFER SYNDROME	0.014803140000000001	0.5544602211683187
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.014798689	0.5542935063737265
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.014741049999999999	0.5521346040943506
VELO-FACIAL-SKELETAL SYNDROME	0.01472412	0.5515004810944749
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.01472412	0.5515004810944749
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.014719843	0.5513402835711159
PRADER-WILLI SYNDROME; PWS	0.014707053000000001	0.5508612266798927
SPINOCEREBELLAR ATAXIA TYPE 13	0.014600473	0.5468692107716381
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.014591339999999998	0.5465271289430577
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.014591339999999998	0.5465271289430577
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.014591339999999998	0.5465271289430577
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.014591339999999998	0.5465271289430577
FAMILIAL LAMBDOID SYNOSTOSIS	0.014591339999999998	0.5465271289430577
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.014578992999999998	0.546064664874572
MICROFORM HOLOPROSENCEPHALY	0.014562759	0.5454566109596292
CATEL-MANZKE SYNDROME; CATMANS	0.014450983	0.5412699758483414
AMISH LETHAL MICROCEPHALY	0.01444966	0.5412204221136198
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01444966	0.5412204221136198
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.5412204221136198
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01444966	0.5412204221136198
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.014444819000000001	0.5410390996421255
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.01439201	0.539061107822844
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.014313629999999999	0.5361253393213522
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.0142857	0.5350792049216755
MYOPATHY, DISTAL 3	0.0142857	0.5350792049216755
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.5350792049216755
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0142857	0.5350792049216755
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.0142857	0.5350792049216755
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.0142857	0.5350792049216755
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.5350792049216755
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.0142857	0.5350792049216755
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0142857	0.5350792049216755
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.5350792049216755
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0142857	0.5350792049216755
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.5350792049216755
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0142857	0.5350792049216755
HYPOPHOSPHATASIA, ADULT	0.0142857	0.5350792049216755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.0142857	0.5350792049216755
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.5350792049216755
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0142857	0.5350792049216755
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0142857	0.5350792049216755
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.0142857	0.5350792049216755
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.0142857	0.5350792049216755
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0142857	0.5350792049216755
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5335230753202085
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5335230753202085
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.5335230753202085
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5335230753202085
NEONATAL ADRENOLEUKODYSTROPHY	0.014223809	0.5327610415084856
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.014174289	0.5309062410977446
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.014123149999999998	0.5289908001000693
OGDEN SYNDROME	0.014059054	0.5265900471290103
ZEBRA BODY MYOPATHY	0.014059054	0.5265900471290103
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.014059054	0.5265900471290103
CITRULLINEMIA TYPE I	0.014054918999999999	0.5264351682982668
RAPID-ONSET DYSTONIA-PARKINSONISM	0.014054918999999999	0.5264351682982668
KUFOR-RAKEB SYNDROME	0.014054918999999999	0.5264351682982668
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014004494	0.5245464705859968
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.013891833000000001	0.5203266872848159
CRANIOFACIAL DYSSYNOSTOSIS	0.01372817	0.5141965944006662
ROBERTS SYNDROME	0.013722894000000001	0.5139989787510889
DILATED CARDIOMYOPATHY WITH ATAXIA	0.013716488999999998	0.5137590757496593
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5130890328468373
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5130890328468373
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5130890328468373
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5130890328468373
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5130890328468373
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5130890328468373
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5130890328468373
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5130890328468373
PEHO-LIKE SYNDROME; PEHOL	0.013671173999999998	0.5120617760603877
RING CHROMOSOME 14 SYNDROME	0.013671173999999998	0.5120617760603877
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671173999999998	0.5120617760603877
HALL-RIGGS SYNDROME	0.013593969	0.5091700178675111
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.013577912999999999	0.5085686310461287
DIAPHANOSPONDYLODYSOSTOSIS	0.013575223999999999	0.5084679129866683
20Q13.33 MICRODELETION SYNDROME	0.013571088999999998	0.5083130341559248
CARNOSINASE DEFICIENCY	0.013569600000000001	0.5082572627946246
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.013555372999999999	0.5077243822323545
WOLFRAM-LIKE SYNDROME	0.01355449	0.507691308953625
FAMILIAL PAROXYSMAL ATAXIA	0.0135135	0.5061560046556389
ACERULOPLASMINEMIA	0.0135135	0.5061560046556389
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT17 TYPE	0.0135135	0.5061560046556389
DYSTONIA 13, TORSION	0.0135135	0.5061560046556389
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT4 TYPE	0.0135135	0.5061560046556389
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0135135	0.5061560046556389
SPASMUS NUTANS	0.0135135	0.5061560046556389
BETHLEM MYOPATHY 1	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT13 TYPE	0.0135135	0.5061560046556389
DYSTONIA 26, MYOCLONIC; DYT26	0.0135135	0.5061560046556389
DYSTONIA 11, MYOCLONIC	0.0135135	0.5061560046556389
DYSTONIA 25	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT6 TYPE	0.0135135	0.5061560046556389
MYOCLONUS-DYSTONIA SYNDROME	0.0135135	0.5061560046556389
AUTOSOMAL DOMINANT FOCAL DYSTONIA, DYT25 TYPE	0.0135135	0.5061560046556389
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.0135135	0.5061560046556389
DYSTONIA 7, TORSION	0.0135135	0.5061560046556389
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0135135	0.5061560046556389
DYSTONIA 23; DYT23	0.0135135	0.5061560046556389
DYSTONIA 12; DYT12	0.0135135	0.5061560046556389
BETHLEM MYOPATHY	0.0135135	0.5061560046556389
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.0135135	0.5061560046556389
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	0.0135135	0.5061560046556389
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.0135135	0.5061560046556389
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0135135	0.5061560046556389
DYSTONIA 16	0.0135135	0.5061560046556389
DYSTONIA 21; DYT21	0.0135135	0.5061560046556389
SPRENGEL DEFORMITY	0.0135135	0.5061560046556389
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.0135135	0.5061560046556389
TORTICOLLIS	0.0135135	0.5061560046556389
SANDIFER SYNDROME	0.0135135	0.5061560046556389
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT21 TYPE	0.0135135	0.5061560046556389
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT2 TYPE	0.0135135	0.5061560046556389
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.0135135	0.5061560046556389
SPINOCEREBELLAR ATAXIA TYPE 17	0.0135135	0.5061560046556389
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.0135135	0.5061560046556389
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0135135	0.5061560046556389
SPINOCEREBELLAR ATAXIA TYPE 35	0.0135135	0.5061560046556389
TRISOMY X	0.013507613	0.5059355036455818
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.013492070000000002	0.5053533315376629
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.013461833	0.5042207871107732
SMITH-MAGENIS SYNDROME	0.013443572999999999	0.5035368481871033
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.013384054	0.5013075294139433
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.013379919	0.5011526505831999
FREEMAN-SHELDON SYNDROME	0.013362989999999998	0.500518565038906
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.013305034	0.49834778934009955
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.013302109	0.4982382317633342
COSTELLO SYNDROME; CSTLO	0.013282934	0.49752002098231735
VASCULAR EHLERS-DANLOS SYNDROME	0.013282934	0.49752002098231735
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.013277414000000001	0.4973132661707808
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.013251909	0.49635796155696926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.013244592999999999	0.4960839365205197
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.013244592999999999	0.4960839365205197
KLEEFSTRA SYNDROME	0.013229809	0.49553019319918706
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.013228999999999998	0.4954998916335107
ATELOSTEOGENESIS, TYPE I; AO1	0.01315524	0.49273716791993544
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.013149404	0.49251857714455005
RAINE SYNDROME	0.013121033999999998	0.4914559622888812
DESANTO-SHINAWI SYNDROME	0.013088523000000001	0.4902382438689783
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.013051564	0.48885392302122843
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.013051564	0.48885392302122843
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013032358999999999	0.48813458857275743
ALLAN-HERNDON-DUDLEY SYNDROME	0.01302539	0.4878735606231926
22Q11.2 DELETION SYNDROME	0.013003613	0.4870578904183319
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.012941192999999998	0.48471991300236955
MUCOPOLYSACCHARIDOSIS TYPE 3	0.012916279	0.48378674463740196
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.012837164	0.48082344628328716
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.012816399999999999	0.4800457185827898
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.012816084	0.4800338826189411
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01280486	0.47961348116881675
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.012722809	0.47654021322653684
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.012672212999999998	0.4746451106097789
FRYNS SYNDROME	0.012638269	0.47337371834115644
INTELLECTUAL DISABILITY, WOLFF TYPE	0.012638269	0.47337371834115644
HENNEKAM-BEEMER SYNDROME	0.012638269	0.47337371834115644
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4712389000008779
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.012575479999999998	0.47102191981551
FIBROCHONDROGENESIS	0.012575479999999998	0.47102191981551
WEBB-DATTANI SYNDROME; WEDAS	0.012559423	0.4704204955385458
GAUCHER DISEASE TYPE 2	0.01250601	0.46841988054785716
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01250601	0.46841988054785716
FACIOCARDIORENAL SYNDROME	0.012490939999999999	0.46785542493012966
LIG4 SYNDROME	0.012484294000000002	0.46760649513348623
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.012398243	0.46438340486400587
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.012395639000000002	0.4642858705289985
19P13.13 MICRODELETION SYNDROME	0.012338893	0.46216041608416997
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01229263	0.460427608503352
MATERNAL PHENYLKETONURIA	0.012287672999999999	0.46024194118436884
COG8-CDG	0.012259169	0.45917430728073894
COFFIN-SIRIS SYNDROME 7; CSS7	0.012215334000000001	0.45753244185253156
20P13 MICRODELETION SYNDROME	0.012211198999999999	0.4573775630217881
SYNDROMIC DIARRHEA	0.012193214	0.45670392438311336
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.012163549	0.4555928045490134
OROFACIODIGITAL SYNDROME TYPE 1	0.012158109	0.4553890461840209
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01215762	0.45537073040452064
DISTAL MONOSOMY 10P	0.01209685	0.4530945546985286
CHROMOSOME 9P DELETION SYNDROME	0.012078024000000001	0.45238941591556
CHROMOSOME 16Q22 DELETION SYNDROME	0.012078024000000001	0.45238941591556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.45095973635825015
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45095973635825015
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45095973635825015
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45095973635825015
FUMARASE DEFICIENCY; FMRD	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45095973635825015
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.45095973635825015
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45095973635825015
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.012013869	0.4499864530651746
CLASSICAL EHLERS-DANLOS SYNDROME	0.01199932	0.4494415118055649
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01195033	0.44760656285317807
VAN MALDERGEM SYNDROME 2; VMLDS2	0.01185422	0.44400670688637056
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01185422	0.44400670688637056
1Q21.1 MICRODUPLICATION SYNDROME	0.011854192999999999	0.4440056955856619
MONOSOMY 18P	0.011808674	0.44230075495770327
ROIFMAN-CHITAYAT SYNDROME	0.011769454	0.4408317470395034
OROFACIODIGITAL SYNDROME I; OFD1	0.011742119	0.4398078987109977
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.011741132999999999	0.43977096750734274
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.011741132999999999	0.43977096750734274
GABRIELE-DE VRIES SYNDROME; GADEVS	0.011728814	0.4393095521951474
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.011719094	0.43894548394005034
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.011719094	0.43894548394005034
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.011719094	0.43894548394005034
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.011652843999999999	0.43646405164579377
PELGER-HUET ANOMALY; PHA	0.011652843999999999	0.43646405164579377
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.011629328999999999	0.43558328363976445
COFFIN-LOWRY SYNDROME	0.011629328999999999	0.43558328363976445
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01161701	0.4351218683275691
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.01161701	0.4351218683275691
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.011613272999999999	0.43498189681838206
KLEEFSTRA SYNDROME 2; KLEFS2	0.011613272999999999	0.43498189681838206
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.011613272999999999	0.43498189681838206
SHORT SYNDROME	0.01158524	0.43393190449377994
CRI-DU-CHAT SYNDROME	0.011532470000000001	0.4319553734421887
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4305256938848789
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4305256938848789
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4305256938848789
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4305256938848789
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4305256938848789
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4305256938848789
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.011472772999999999	0.42971938757546807
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.011472772999999999	0.42971938757546807
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011454973	0.42905267821942644
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.011420449999999999	0.4277595991689415
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.011413943	0.42751587569816835
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011413943	0.42751587569816835
ULBRIGHT-HODES SYNDROME	0.011398349999999998	0.42693183081115926
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.011398349999999998	0.42693183081115926
PRUNE BELLY SYNDROME	0.011398349999999998	0.42693183081115926
RENAL AGENESIS	0.011398349999999998	0.42693183081115926
ARTERIAL TORTUOSITY SYNDROME	0.011334874000000002	0.4245543003008164
2Q23.1 MICRODELETION SYNDROME	0.011330739000000001	0.4243994214700729
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.011312774000000001	0.4237265319430341
CHROMOSOME 18P DELETION SYNDROME	0.011312504000000001	0.42371641893594814
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.011290383999999999	0.4228879014665298
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0112239	0.4203977045661321
CRANIOECTODERMAL DYSPLASIA 1	0.0112007	0.4195287350683698
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0112007	0.4195287350683698
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.011195578999999999	0.41933692503397146
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.011184764	0.41893184291680347
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.011184764	0.41893184291680347
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.011184764	0.41893184291680347
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.011180629000000001	0.4187769640860601
TEMPLE SYNDROME	0.011128160000000002	0.4168117071645907
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.011106060000000001	0.4159839388068085
COFFIN-SIRIS SYNDROME 2; CSS2	0.011072663	0.41473303474143053
ISOLATED PLAGIOCEPHALY	0.011071853999999999	0.4147027331757542
CRANIOSYNOSTOSIS 6; CRS6	0.011071853999999999	0.4147027331757542
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.011071853999999999	0.4147027331757542
BRESEK SYNDROME	0.011071853999999999	0.4147027331757542
LINEAR NEVUS SEBACEUS SYNDROME	0.011067718999999998	0.4145478543450108
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.011067718999999998	0.4145478543450108
19P13.12 MICRODELETION SYNDROME	0.011061073	0.41429892454836736
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.011061073	0.41429892454836736
MONOSOMY 18Q	0.011038972999999999	0.4134711561905851
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.011015292999999999	0.4125842080135588
MONOSOMY 5P	0.01100337	0.4121376251117563
CINCA SYNDROME	0.010998094	0.4119400094621789
MENTAL RETARDATION, X-LINKED 104; MRX104	0.010988123	0.4115665398560502
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.010976553	0.411133178774623
WEAVER SYNDROME	0.010976553	0.411133178774623
PALLISTER-KILLIAN SYNDROME	0.010927219000000002	0.409285345102097
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.010834554	0.40581452361459075
RETT SYNDROME	0.010823309	0.4053933355972486
RETT SYNDROME, CONGENITAL VARIANT	0.010801208999999999	0.4045655672394664
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.010789320000000002	0.4041202578274451
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.010782813	0.4038765343566718
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.010782813	0.4038765343566718
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.010782813	0.4038765343566718
FUCOSIDOSIS	0.010769992999999999	0.4033963537979945
TARP SYNDROME; TARPS	0.010768454	0.40333870965760416
TIBIAL HEMIMELIA	0.010767220000000001	0.40329248946966284
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.010767220000000001	0.40329248946966284
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.010767220000000001	0.40329248946966284
FEMORAL-FACIAL SYNDROME	0.010767220000000001	0.40329248946966284
SCHWARTZ-JAMPEL SYNDROME	0.010767220000000001	0.40329248946966284
CAMPOMELIA, CUMMING TYPE	0.010744829999999999	0.40245385899315855
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.010744829999999999	0.40245385899315855
BOWEN-CONRADI SYNDROME	0.010673629	0.39978698411340985
FIBROCHONDROGENESIS 1; FBCG1	0.01066131	0.3993255688012144
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.01066131	0.3993255688012144
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.01066131	0.3993255688012144
MECKEL SYNDROME 12; MKS12	0.01066029	0.3992873641077782
OCCIPITAL HORN SYNDROME	0.010659254	0.3992485601250334
THANATOPHORIC DYSPLASIA	0.010655119000000001	0.39909368129429
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.010655119	0.3990936812942899
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.01065416	0.39905776139134364
1Q41Q42 MICRODELETION SYNDROME	0.010651529	0.39895921575562754
MEHMO SYNDROME	0.010651529	0.39895921575562754
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01063921	0.3984978004434322
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.01063921	0.3984978004434322
AASE-SMITH SYNDROME I	0.01063921	0.3984978004434322
HYDROLETHALUS SYNDROME 1	0.01063921	0.3984978004434322
CARDIOFACIOCUTANEOUS SYNDROME	0.010580234	0.39628882005118954
HEREDITARY OROTIC ACIDURIA	0.010574714	0.39608206523965306
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010531244	0.3944538710988027
ROBINOW-SORAUF SYNDROME	0.010526299999999999	0.3942686907023829
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.010519654000000002	0.3940197609057396
WHIPPLE DISEASE	0.010469738999999999	0.3921501655401875
ADIPOSIS DOLOROSA	0.010469738999999999	0.3921501655401875
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.010469738999999999	0.3921501655401875
ALEXANDER DISEASE	0.010469738999999999	0.3921501655401875
CORNEODERMATOOSSEOUS SYNDROME	0.01045254	0.3915059669888077
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.01045254	0.3915059669888077
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.010368	0.38833947210342734
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.01032697	0.3868026695821692
ACRORENAL-MANDIBULAR SYNDROME	0.01032697	0.3868026695821692
RENAL AGENESIS, BILATERAL	0.01032697	0.3868026695821692
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.010307440000000001	0.38607116206961334
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.010300913	0.38582668948720406
KOOLEN-DE VRIES SYNDROME	0.010300913	0.38582668948720406
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.010289	0.3853804811412195
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.010289	0.3853804811412195
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.010275382999999999	0.3848704484838475
C SYNDROME	0.010238493	0.38348871207124186
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.010238493	0.38348871207124186
CHROMOSOME 10Q26 DELETION SYNDROME	0.010238493	0.38348871207124186
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.0102229	0.38290466718423294
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.010114934	0.37886073783960345
MULTIPLE EPIPHYSEAL DYSPLASIA	0.0101137	0.3788145176516621
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.010113384000000001	0.37880268168781334
FETAL HYDANTOIN SYNDROME	0.010113384000000001	0.37880268168781334
16P11.2P12.2 MICRODELETION SYNDROME	0.010113384000000001	0.37880268168781334
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.010113384	0.3788026816878133
TETRASOMY 5P	0.010110433	0.3786921502659212
SIMPSON-GOLABI-BEHMEL SYNDROME	0.010110433	0.3786921502659212
1Q21.1 MICRODELETION SYNDROME	0.010110433	0.3786921502659212
MECKEL SYNDROME, TYPE 10; MKS10	0.010109249	0.3786478028570699
LARSEN-LIKE SYNDROME	0.010038094000000001	0.37598265093408384
GMS SYNDROME	0.01003468	0.3758547775778183
DIAMOND-BLACKFAN ANEMIA 1	0.01003468	0.3758547775778183
CONO-SPONDYLAR DYSPLASIA	0.009998008999999999	0.3744812439376268
FOCAL DERMAL HYPOPLASIA; FDH	0.00998569	0.3740198286254314
PELVISCAPULAR DYSPLASIA	0.00998569	0.3740198286254314
WILLIAMS-BEUREN SYNDROME; WBS	0.0099741	0.37358571843236826
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.009951703	0.3727468257667914
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.009913469	0.3713147490522465
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.009913469	0.3713147490522465
GLUTAMINE DEFICIENCY, CONGENITAL	0.009913469	0.3713147490522465
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.009913469	0.3713147490522465
TRISOMY 18-LIKE SYNDROME	0.009901150000000001	0.3708533337400511
BRANCHIO-OCULO-FACIAL SYNDROME	0.009901150000000001	0.3708533337400511
SIMOSA CRANIOFACIAL SYNDROME	0.009901150000000001	0.3708533337400511
BARBER-SAY SYNDROME	0.009901150000000001	0.3708533337400511
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00988958	0.3704199726586239
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00988958	0.3704199726586239
FILIPPI SYNDROME	0.009841453	0.3686173478733305
WOLCOTT-RALLISON SYNDROME	0.009839899	0.3685591418992132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.3672450128117567
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3672450128117567
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.3672450128117567
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3672450128117567
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3672450128117567
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3672450128117567
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3672450128117567
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3672450128117567
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.3672450128117567
BIOTINIDASE DEFICIENCY	0.009804814	0.3672450128117567
KRABBE DISEASE	0.009804814	0.3672450128117567
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36709013398101326
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36709013398101326
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.009782622999999999	0.36641383599603067
17Q12 MICRODELETION SYNDROME	0.009782622999999999	0.36641383599603067
ADAMS-OLIVER SYNDROME 2; AOS2	0.009782622999999999	0.36641383599603067
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.009781614	0.36637604331399437
OROFACIODIGITAL SYNDROME VI	0.009781614	0.36637604331399437
OLIVER SYNDROME	0.00976705	0.3658305402206577
OCULOSKELETODENTAL SYNDROME; OCSKD	0.009759494	0.3655475258445762
METAPHYSEAL ACROSCYPHODYSPLASIA	0.009710179999999999	0.36370044128368606
METAPHYSEAL ACROSCYPHODYSPLASIA	0.009710179999999999	0.36370044128368606
LAMB-SHAFFER SYNDROME	0.009697074000000002	0.3632095484286141
MONOSOMY X	0.00969584	0.3631633282406727
MOSAIC MONOSOMY X	0.00969584	0.3631633282406727
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00969584	0.3631633282406727
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00969584	0.3631633282406727
TURNER SYNDROME	0.00969584	0.3631633282406727
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00969584	0.3631633282406727
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00968302	0.36268314768199544
DUPLICATION/INVERSION 15Q11	0.009649419	0.3614246026779303
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0096318	0.3607646727821943
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.009580149	0.3588300545266374
ROBERTS SYNDROME; RBS	0.00956938	0.3584266953662322
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.009567830000000001	0.35836863921444206
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.009567830000000001	0.35836863921444206
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00949254	0.35554860846071257
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.009490333	0.35546594399167974
CONGENITAL TOXOPLASMOSIS	0.009490333	0.35546594399167974
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.35546594399167974
GALLOWAY-MOWAT SYNDROME	0.009490333	0.35546594399167974
KAGAMI-OGATA SYNDROME	0.009490333	0.35546594399167974
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.35546594399167974
KAGAMI-OGATA SYNDROME	0.009490333	0.35546594399167974
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.35546594399167974
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009462353	0.354417936812913
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.009429752999999999	0.3531968848462297
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.009407652999999998	0.3523691164884475
PETERS PLUS SYNDROME	0.009384574	0.351504679116083
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00937205	0.35103558540961866
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.009347864	0.35012968470820144
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.009300034	0.3483381842307027
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.009295899	0.3481833053999593
HYDROXYLYSINURIA	0.00925926	0.3468109703383854
CARNOSINEMIA	0.00925926	0.3468109703383854
GAUCHER DISEASE TYPE 3	0.00925926	0.3468109703383854
PAINE SYNDROME	0.00925926	0.3468109703383854
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3468109703383854
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3468109703383854
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3468109703383854
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3468109703383854
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3468109703383854
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3468109703383854
GLYCINE ENCEPHALOPATHY	0.00925926	0.3468109703383854
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3468109703383854
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3468109703383854
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3468109703383854
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.009241204	0.34613467235340284
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.009241204	0.34613467235340284
EVEN-PLUS SYNDROME	0.009241204	0.34613467235340284
OROFACIODIGITAL SYNDROME TYPE 4	0.009241204	0.34613467235340284
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.009237068999999999	0.3459797935226594
HADDAD SYNDROME	0.009237068999999999	0.3459797935226594
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.009237068999999999	0.3459797935226594
OROFACIODIGITAL SYNDROME IV; OFD4	0.009236059999999999	0.3459420008406231
1Q44 MICRODELETION SYNDROME	0.009219124	0.3453076531072567
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00921394	0.34511348337120495
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00921394	0.34511348337120495
MOEBIUS SYNDROME	0.009108	0.3411454390353025
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.3385508908840096
TRISOMY XQ28	0.00903873	0.3385508908840096
COFFIN-SIRIS SYNDROME 1; CSS1	0.009023483	0.3379798056283035
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.009023483	0.3379798056283035
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.009023483	0.3379798056283035
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.009001063	0.3371400514843453
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.3351867803490519
TYSHCHENKO SYNDROME	0.008948914	0.3351867803490519
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.3351867803490519
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3350319015183085
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.3350319015183085
DYSOSTEOSCLEROSIS	0.008916799	0.3339838943395417
WOODHOUSE-SAKATI SYNDROME	0.00886473	0.3320336196507923
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.008862098999999998	0.3319350740150762
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.008799679000000001	0.3295970965991141
SIALURIA	0.008747973	0.3276604182865581
TEEBI-SHALTOUT SYNDROME; TBSH	0.00873238	0.3270763733995492
HOLZGREVE SYNDROME	0.00869565	0.32570062988003157
46,XX DISORDER OF SEX DEVELOPMENT-ANORECTAL ANOMALIES SYNDROME	0.00869565	0.32570062988003157
HB BART'S HYDROPS FETALIS	0.00869565	0.32570062988003157
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.32570062988003157
THOMAS SYNDROME	0.00869565	0.32570062988003157
TRANSALDOLASE DEFICIENCY	0.00869565	0.32570062988003157
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00869565	0.32570062988003157
POSTERIOR URETHRAL VALVE	0.00869565	0.32570062988003157
ACRO-RENAL-MANDIBULAR SYNDROME	0.00869565	0.32570062988003157
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.32570062988003157
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.00869565	0.32570062988003157
SERKAL SYNDROME	0.00869565	0.32570062988003157
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00869565	0.32570062988003157
ABSENT RADIUS-ANOGENITAL ANOMALIES SYNDROME	0.00869565	0.32570062988003157
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00869565	0.32570062988003157
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00869565	0.32570062988003157
HEMOCHROMATOSIS, NEONATAL	0.00869565	0.32570062988003157
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00869565	0.32570062988003157
SCHAAF-YANG SYNDROME; SHFYNG	0.008691713	0.32555316725448463
MYHRE SYNDROME	0.008691713	0.32555316725448463
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.008691713	0.32555316725448463
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.008669593	0.3247246497850664
NIEMANN-PICK DISEASE TYPE C	0.008644063	0.32376840878170987
AICARDI-GOUTIERES SYNDROME 7	0.008644063	0.32376840878170987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.008644063	0.32376840878170987
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.008644063	0.32376840878170987
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.008644063	0.32376840878170987
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.008644063	0.32376840878170987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.008644063	0.32376840878170987
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.008644063	0.32376840878170987
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.008644063	0.32376840878170987
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.008644063	0.32376840878170987
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.008644063	0.32376840878170987
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.008644063	0.32376840878170987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.008644063	0.32376840878170987
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.008644063	0.32376840878170987
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.008644063	0.32376840878170987
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.008610074	0.3224953310119063
AU-KLINE SYNDROME; AUKS	0.008610074	0.3224953310119063
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.008610074	0.3224953310119063
ALPHA-MANNOSIDOSIS	0.008610074	0.3224953310119063
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008494383	0.31816205729787106
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.31816205729787106
ADENYLOSUCCINASE DEFICIENCY	0.008494383	0.31816205729787106
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.008494383	0.31816205729787106
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.31816205729787106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.008482064000000001	0.31770064198567566
OTOPALATODIGITAL SYNDROME TYPE 2	0.008482064000000001	0.31770064198567566
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008482064000000001	0.31770064198567566
OROFACIODIGITAL SYNDROME XIV; OFD14	0.008482064000000001	0.31770064198567566
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.008482064000000001	0.31770064198567566
COCKAYNE SYNDROME A; CSA	0.008477929	0.3175457631549322
BARAITSER-WINTER SYNDROME 2; BRWS2	0.008477929	0.3175457631549322
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.008477929	0.3175457631549322
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.008477929	0.3175457631549322
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008477929	0.3175457631549322
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31475273787568064
FATCO SYNDROME	0.00840336	0.31475273787568064
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.31475273787568064
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.31475273787568064
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31475273787568064
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31475273787568064
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31475273787568064
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.31475273787568064
RETINOPATHY OF PREMATURITY	0.00840336	0.31475273787568064
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31475273787568064
VACTERL/VATER ASSOCIATION	0.00840336	0.31475273787568064
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31475273787568064
HEC SYNDROME	0.00840336	0.31475273787568064
OMPHALOCELE	0.00840336	0.31475273787568064
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31475273787568064
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31475273787568064
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31475273787568064
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31475273787568064
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.31475273787568064
SCHISIS ASSOCIATION	0.00840336	0.31475273787568064
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31475273787568064
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31475273787568064
EBSTEIN MALFORMATION	0.00840336	0.31475273787568064
HYDROLETHALUS	0.00840336	0.31475273787568064
PEMPHIGOID GESTATIONIS	0.00840336	0.31475273787568064
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.31475273787568064
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31475273787568064
NEMALINE MYOPATHY 10	0.00840336	0.31475273787568064
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.31475273787568064
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.31475273787568064
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00839906	0.31459167887394024
MONOSOMY 13Q14	0.00836994	0.3135009723319213
NON-DISTAL MONOSOMY 10Q	0.00836994	0.3135009723319213
HALLERMANN-STREIFF SYNDROME	0.008342780000000001	0.3124836787302307
JOHANSON-BLIZZARD SYNDROME; JBS	0.008342780000000001	0.3124836787302307
TOWNES-BROCKS SYNDROME	0.008342780000000001	0.3124836787302307
POTOCKI-SHAFFER SYNDROME	0.008336273	0.3122399552594574
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.008291093999999999	0.31054774952931063
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008273853	0.30990197784349516
MENTAL RETARDATION, X-LINKED 91; MRX91	0.008273853	0.30990197784349516
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00825826	0.30931793295648624
OGDEN SYNDROME; OGDNS	0.008206554000000001	0.3073812546439304
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.008206554000000001	0.3073812546439304
OPITZ G/BBB SYNDROME	0.008206554000000001	0.3073812546439304
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.008202418999999999	0.3072263758131869
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.008150294	0.30527400361185675
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.008150293999999999	0.30527400361185675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.008146159	0.30511912478111336
48,XXXY SYNDROME	0.008145793	0.30510541603817454
49,XXXXY SYNDROME	0.008145793	0.30510541603817454
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.008102643999999999	0.303489245139082
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.008102643999999999	0.303489245139082
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.008102643999999999	0.303489245139082
AICARDI-GOUTIERES SYNDROME 6	0.008102643999999999	0.303489245139082
KLEEFSTRA SYNDROME	0.008100013	0.30339069950336595
CEREBROTENDINOUS XANTHOMATOSIS	0.008098509	0.30333436630833865
RETT SYNDROME; RTT	0.008098509	0.30333436630833865
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.008098509	0.30333436630833865
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.008098509	0.30333436630833865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.008098509	0.30333436630833865
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.008098509	0.30333436630833865
GM2 GANGLIOSIDOSIS, AB VARIANT	0.008098509	0.30333436630833865
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.008098509	0.30333436630833865
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.008098509	0.30333436630833865
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.008098509	0.30333436630833865
SHORT SYNDROME	0.00807886	0.3025984015815485
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.008065754000000001	0.3021075087264764
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.008065754000000001	0.3021075087264764
GOLDBERG-SHPRINTZEN SYNDROME	0.008065754000000001	0.3021075087264764
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.008065754000000001	0.3021075087264764
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.3020612885385351
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00806452	0.3020612885385351
CLASSIC MULTIMINICORE MYOPATHY	0.00806452	0.3020612885385351
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00806452	0.3020612885385351
DIASTROPHIC DWARFISM	0.00806452	0.3020612885385351
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00806452	0.3020612885385351
CAT-EYE SYNDROME	0.00806452	0.3020612885385351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00806452	0.3020612885385351
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00806452	0.3020612885385351
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00806452	0.3020612885385351
SPONASTRIME DYSPLASIA	0.00806452	0.3020612885385351
CRANIOECTODERMAL DYSPLASIA 4	0.00806452	0.3020612885385351
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00806452	0.3020612885385351
BRITTLE CORNEA SYNDROME	0.00806452	0.3020612885385351
DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2	0.00806452	0.3020612885385351
13Q12.3 MICRODELETION SYNDROME	0.00806452	0.3020612885385351
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.3020612885385351
COXOPODOPATELLAR SYNDROME	0.00806452	0.3020612885385351
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00806452	0.3020612885385351
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00806452	0.3020612885385351
MEIER-GORLIN SYNDROME 6; MGORS6	0.00806452	0.3020612885385351
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00806452	0.3020612885385351
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00806452	0.3020612885385351
PITT-HOPKINS SYNDROME	0.008061619	0.301952629895733
SPINOCEREBELLAR ATAXIA 47; SCA47	0.008061619	0.301952629895733
311450 PALLISTER W SYNDROME;;W SYNDROME	0.008061619	0.301952629895733
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.29788289365524323
300270 ADRENOMYODYSTROPHY	0.007952964	0.29788289365524323
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.29788289365524323
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.007948829	0.29772801482449973
ADRENOMYODYSTROPHY	0.007948829	0.29772801482449973
LISSENCEPHALY 5; LIS5	0.007948829	0.29772801482449973
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.29772801482449973
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.007948829	0.29772801482449973
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.29772801482449973
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007948829	0.29772801482449973
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.29772801482449973
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.007948829	0.29772801482449973
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.29772801482449973
LOWRY-MACLEAN SYNDROME	0.007948829	0.29772801482449973
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.007948829	0.29772801482449973
2Q24 MICRODELETION SYNDROME	0.007948829	0.29772801482449973
DPM1-CDG	0.007948829	0.29772801482449973
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.29772801482449973
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.29772801482449973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.007948829	0.29772801482449973
4Q21 MICRODELETION SYNDROME	0.007948829	0.29772801482449973
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.29772801482449973
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.29772801482449973
SMITH-FINEMAN-MYERS SYNDROME	0.007948829	0.29772801482449973
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.29772801482449973
CROME SYNDROME	0.007948829	0.29772801482449973
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.29772801482449973
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00793651	0.2972665995123044
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00793651	0.2972665995123044
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00793651	0.2972665995123044
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00793651	0.2972665995123044
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00793651	0.2972665995123044
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00793651	0.2972665995123044
ACROCRANIOFACIAL DYSOSTOSIS	0.00793651	0.2972665995123044
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00793651	0.2972665995123044
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00793651	0.2972665995123044
BRANCHIOOTIC SYNDROME 2	0.00793651	0.2972665995123044
BARBER-SAY SYNDROME; BBRSAY	0.00793651	0.2972665995123044
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00793651	0.2972665995123044
NEU-LAXOVA SYNDROME 2; NLS2	0.00793651	0.2972665995123044
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00793651	0.2972665995123044
184705 STEINFELD SYNDROME	0.00793651	0.2972665995123044
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00793651	0.2972665995123044
KENNERKNECHT SYNDROME	0.00793651	0.2972665995123044
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00793651	0.2972665995123044
POLYVALVULAR HEART DISEASE SYNDROME	0.00793651	0.2972665995123044
MAXILLOFACIAL DYSOSTOSIS	0.00793651	0.2972665995123044
PYRUVATE DEHYDROGENASE DEFICIENCY	0.007929683	0.2970108902553551
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.007854713	0.29420284528780166
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.007825593	0.2931121387457828
LYMPHEDEMA, HEREDITARY, III	0.007794854	0.2919607916168296
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.007790719	0.29180591278608614
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007732434	0.2896228142008674
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.007732434	0.2896228142008674
WARSAW BREAKAGE SYNDROME; WABS	0.007732434	0.2896228142008674
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.007732434	0.2896228142008674
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.007732434	0.2896228142008674
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.007667159999999999	0.2871779385544477
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.007660999999999999	0.2869472121705591
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.007660999999999999	0.2869472121705591
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.007660999999999999	0.2869472121705591
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0076047400000000005	0.28483996113848553
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.0076047400000000005	0.28483996113848553
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.0076047400000000005	0.28483996113848553
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.0076047400000000005	0.28483996113848553
DISTAL MONOSOMY 6P	0.0076043740000000005	0.2848262523955467
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.284205613405119
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.284205613405119
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.284205613405119
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.284205613405119
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.284205613405119
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28405073457437563
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28405073457437563
JUNG SYNDROME	0.00758262	0.28401144366906733
ATAXIA WITH VITAMIN E DEFICIENCY	0.007557090000000001	0.2830552026657108
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.007557090000000001	0.2830552026657108
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.007557090000000001	0.2830552026657108
NEUROFERRITINOPATHY	0.007557090000000001	0.2830552026657108
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.007557090000000001	0.2830552026657108
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.0075202	0.28167346625310513
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0075202	0.28167346625310513
11Q22.2Q22.3 MICRODELETION SYNDROME	0.007492272999999999	0.2806274442201737
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.007407733	0.27746094933479337
MONOSOMY 22Q13.3	0.007407733	0.27746094933479337
20Q11.2 MICRODUPLICATION SYNDROME	0.007407733	0.27746094933479337
MAN1B1-CDG	0.007407733	0.27746094933479337
PHELAN-MCDERMID SYNDROME	0.007407733	0.27746094933479337
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007407733	0.27746094933479337
KID SYNDROME	0.00740741	0.2774488511818719
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2774488511818719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2774488511818719
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.2774488511818719
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2774488511818719
ZTTK SYNDROME; ZTTKS	0.007361953	0.2757462327999849
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.007313294	0.27392368164517383
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.007313294	0.27392368164517383
SAUL-WILSON SYNDROME; SWILS	0.007313294	0.27392368164517383
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.007309158999999999	0.2737688028144304
FLOATING-HARBOR SYNDROME	0.007284174000000001	0.27283297510315496
45,X/46,XY MIXED GONADAL DYSGENESIS	0.0072493	0.2715267491434583
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0072493	0.2715267491434583
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.0072493	0.2715267491434583
GRACILE BONE DYSPLASIA; GCLEB	0.007201193	0.2697248734698009
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007201193	0.2697248734698009
COFFIN-SIRIS SYNDROME 10; CSS10	0.00718688	0.26918877172749606
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00718688	0.26918877172749606
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00718688	0.26918877172749606
BOHRING-OPITZ SYNDROME	0.007116653	0.26655837858442055
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.007116653	0.26655837858442055
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.007116653	0.26655837858442055
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26377157093174775
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26377157093174775
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26377157093174775
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26377157093174775
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26377157093174775
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26377157093174775
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26377157093174775
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26377157093174775
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26377157093174775
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26377157093174775
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26377157093174775
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26377157093174775
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26377157093174775
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26377157093174775
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26377157093174775
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26377157093174775
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26377157093174775
JABERI-ELAHI SYNDROME; JABELS	0.007036423	0.2635533172565986
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.007028633	0.2632615382743758
RING CHROMOSOME 22 SYNDROME	0.007028633	0.2632615382743758
DUBOWITZ SYNDROME	0.0069467190000000005	0.2601934017468025
TRISOMY 12P	0.006866314	0.25718178569216554
WIEDEMANN-STEINER SYNDROME	0.006862179000000001	0.2570269068614222
CEREBROFACIOARTICULAR SYNDROME	0.0068442139999999995	0.25635401733438334
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.006840079000000001	0.25619913850363996
LATHOSTEROLOSIS	0.006840079000000001	0.25619913850363996
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00678984	0.25431740752958476
PMM2-CDG	0.006783333	0.25407368405881153
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.006783333	0.25407368405881153
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.006783333	0.25407368405881153
DISTAL MONOSOMY 1Q	0.006783332999999999	0.2540736840588115
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0067677399999999995	0.25348963917180256
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0067677399999999995	0.25348963917180256
FRANK-TER HAAR SYNDROME	0.006738620000000001	0.25239893262978375
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.006732113	0.2521552091590104
SMITH-LEMLI-OPITZ SYNDROME	0.006732113	0.2521552091590104
PITUITARY STALK INTERRUPTION SYNDROME	0.006704953	0.25113791555731974
DIGEORGE SYNDROME; DGS	0.006704953	0.25113791555731974
ALSTRÖM SYNDROME	0.006704953	0.25113791555731974
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.006704953	0.25113791555731974
SRD5A3-CDG	0.006704953	0.25113791555731974
TIMOTHY SYNDROME; TS	0.006704953	0.25113791555731974
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.006704953	0.25113791555731974
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.006659773999999999	0.24944570982717304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.006642533	0.24879993814135754
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.006642533	0.24879993814135754
KBG SYNDROME	0.006642533	0.24879993814135754
STEEL SYNDROME; STLS	0.006575234	0.2462792149417927
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.006571099	0.2461243361110493
14Q12 MICRODELETION SYNDROME	0.006483079	0.24282749580100457
URBAN-ROGERS-MEYER SYNDROME	0.006405299999999999	0.23991423810417462
JACOBSEN SYNDROME	0.006405299999999999	0.23991423810417462
CRANIOECTODERMAL DYSPLASIA	0.006405299999999999	0.23991423810417462
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.006405299999999999	0.23991423810417462
CAREY-FINEMAN-ZITER SYNDROME	0.006383199999999999	0.23908646974639242
DUBOWITZ SYNDROME	0.00632076	0.23674774321879427
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.006298659999999999	0.23591997486101207
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.006298659999999999	0.23591997486101207
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0062983629999999995	0.23590885055321745
NOONAN SYNDROME 5; NS5	0.0062419139999999994	0.23379452041618365
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0062419139999999994	0.23379452041618365
FETAL TRIMETHADIONE SYNDROME	0.0062419139999999994	0.23379452041618365
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0062419139999999994	0.23379452041618365
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.006237779	0.23363964158544026
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.006237779	0.23363964158544026
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.006237779	0.23363964158544026
DISTAL MONOSOMY 9P	0.006190694	0.23187604551638258
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.006190694	0.23187604551638258
POTOCKI-SHAFFER SYNDROME	0.0061865589999999995	0.23172116668563916
RABSON-MENDENHALL SYNDROME	0.006163534	0.2308587519146919
THYROID HYPOPLASIA	0.006163534	0.2308587519146919
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.006163534	0.2308587519146919
PRIMARY CONGENITAL HYPOTHYROIDISM	0.006163534	0.2308587519146919
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.006163534	0.2308587519146919
PERIPHERAL HYPOTHYROIDISM	0.006163534	0.2308587519146919
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.006163534	0.2308587519146919
PERMANENT CONGENITAL HYPOTHYROIDISM	0.006163534	0.2308587519146919
TOWNES-BROCKS SYNDROME 1; TBS1	0.006163534	0.2308587519146919
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.006163534	0.2308587519146919
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.006163534	0.2308587519146919
ATHYREOSIS	0.006163534	0.2308587519146919
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.006163534	0.2308587519146919
FAMILIAL THYROID DYSHORMONOGENESIS	0.006163534	0.2308587519146919
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.006163534	0.2308587519146919
THYROID ECTOPIA	0.006163534	0.2308587519146919
LIG4 SYNDROME	0.006163534	0.2308587519146919
ISOLATED BILIARY ATRESIA	0.006159398999999999	0.2307038730839485
COWDEN SYNDROME 6; CWS6	0.006159398999999999	0.2307038730839485
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.006159398999999999	0.2307038730839485
COWDEN SYNDROME 5; CWS5	0.006159398999999999	0.2307038730839485
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.006159398999999999	0.2307038730839485
ODONTOCHONDRODYSPLASIA; ODCD	0.00611422	0.22901166735380182
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00611422	0.22901166735380182
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00611422	0.22901166735380182
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00611422	0.22901166735380182
LARSEN SYNDROME	0.00611422	0.22901166735380182
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.006101114	0.2285207744987297
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.006101114	0.2285207744987297
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.006101114	0.2285207744987297
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.006101114	0.2285207744987297
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.006101114	0.2285207744987297
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.006101114	0.2285207744987297
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.006101114	0.2285207744987297
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006101114	0.2285207744987297
MICROPHTHALMIA, SYNDROMIC 1	0.006096979000000001	0.22836589566798635
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.006096979000000001	0.22836589566798635
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00602968	0.22584517246842145
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00602968	0.22584517246842145
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00602968	0.22584517246842145
ZECHI-CEIDE SYNDROME	0.00602968	0.22584517246842145
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.005973054	0.22372421269340903
2Q32Q33 MICRODELETION SYNDROME	0.005973054	0.22372421269340903
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.005971550000000001	0.22366787949838174
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.005968919	0.22356933386266561
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.005965043	0.22342415602760843
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.005965043	0.22342415602760843
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.005965043	0.22342415602760843
PARKINSONIAN-PYRAMIDAL SYNDROME	0.00594945	0.2228401111405995
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00594945	0.2228401111405995
RUVALCABA SYNDROME	0.005860953	0.21952540451803615
2Q37 MICRODELETION SYNDROME	0.005860953	0.21952540451803615
ADAMS-OLIVER SYNDROME 1; AOS1	0.005838853	0.21869763616025392
TEMTAMY SYNDROME; TEMTYS	0.005838853	0.21869763616025392
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.005776413	0.21635890963265575
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.005754313	0.21553114127487355
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.005696359999999999	0.2133604779428124
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.005696359999999999	0.2133604779428124
CEREBROOCULONASAL SYNDROME	0.005696359999999999	0.2133604779428124
NASODIGITOACOUSTIC SYNDROME	0.005696359999999999	0.2133604779428124
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.005696359999999999	0.2133604779428124
ACRODYSOSTOSIS	0.00564514	0.21144200304301133
DYSBETALIPOPROTEINEMIA	0.00561798	0.21042470944132063
OBESITY-COLITIS-HYPOTHYROIDISM-CARDIAC HYPERTROPHY-DEVELOPMENTAL DELAY SYNDROME	0.00561798	0.21042470944132063
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00561798	0.21042470944132063
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00561798	0.21042470944132063
METHIMAZOLE EMBRYOFETOPATHY	0.00561798	0.21042470944132063
FETAL IODINE SYNDROME	0.00561798	0.21042470944132063
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00561798	0.21042470944132063
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00561798	0.21042470944132063
SARCOIDOSIS	0.00561798	0.21042470944132063
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00561798	0.21042470944132063
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00561798	0.21042470944132063
PRECOCIOUS PUBERTY, CENTRAL	0.00561798	0.21042470944132063
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00561798	0.21042470944132063
BETA-THALASSEMIA INTERMEDIA	0.00561798	0.21042470944132063
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00561798	0.21042470944132063
PSEUDOXANTHOMA ELASTICUM	0.00561798	0.21042470944132063
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00561798	0.21042470944132063
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.00561798	0.21042470944132063
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00561798	0.21042470944132063
CONGENITAL ATRANSFERRINEMIA	0.00561798	0.21042470944132063
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00561798	0.21042470944132063
OMENN SYNDROME	0.00561798	0.21042470944132063
CYSTINOSIS	0.00561798	0.21042470944132063
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00561798	0.21042470944132063
HAWKINSINURIA	0.00561798	0.21042470944132063
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00561798	0.21042470944132063
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00561798	0.21042470944132063
AA AMYLOIDOSIS	0.00561798	0.21042470944132063
PENDRED SYNDROME	0.00561798	0.21042470944132063
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00561798	0.21042470944132063
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.00561798	0.21042470944132063
THYROID LYMPHOMA	0.00561798	0.21042470944132063
POEMS SYNDROME	0.00561798	0.21042470944132063
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00561798	0.21042470944132063
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00561798	0.21042470944132063
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 17-BETA-HYDROXYSTEROID DEHYDROGENASE 3 DEFICIENCY	0.00561798	0.21042470944132063
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.00561798	0.21042470944132063
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00561798	0.21042470944132063
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00561798	0.21042470944132063
SUBCORNEAL PUSTULAR DERMATOSIS	0.00561798	0.21042470944132063
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00561798	0.21042470944132063
GNE MYOPATHY	0.00561798	0.21042470944132063
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00561798	0.21042470944132063
CHARGE SYNDROME	0.00561798	0.21042470944132063
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.00561798	0.21042470944132063
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00561798	0.21042470944132063
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00561798	0.21042470944132063
CENANI-LENZ SYNDROME	0.00561798	0.21042470944132063
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00561798	0.21042470944132063
MYXEDEMA	0.00561798	0.21042470944132063
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00561798	0.21042470944132063
CONGENITAL MACROGLOSSIA	0.00561798	0.21042470944132063
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00561798	0.21042470944132063
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00555556	0.20808673202535846
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00555556	0.20808673202535846
OROFACIODIGITAL SYNDROME XVII	0.00555556	0.20808673202535846
201310 ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE	0.00555556	0.20808673202535846
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00555556	0.20808673202535846
RUIJS-AALFS SYNDROME; RJALS	0.00555556	0.20808673202535846
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00555556	0.20808673202535846
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00555556	0.20808673202535846
MCDONOUGH SYNDROME	0.00555556	0.20808673202535846
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00555556	0.20808673202535846
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00555556	0.20808673202535846
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.00555556	0.20808673202535846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00555556	0.20808673202535846
XYLT1-CDG	0.00555556	0.20808673202535846
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00555556	0.20808673202535846
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00555556	0.20808673202535846
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.00555556	0.20808673202535846
109300 BANKI SYNDROME	0.00555556	0.20808673202535846
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00555556	0.20808673202535846
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00555556	0.20808673202535846
ESOPHAGEAL ATRESIA	0.00555556	0.20808673202535846
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00555556	0.20808673202535846
WAHAB SYNDROME	0.00555556	0.20808673202535846
15Q11Q13 MICRODUPLICATION SYNDROME	0.0054430929999999995	0.2038742151070467
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0054430929999999995	0.2038742151070467
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0054430929999999995	0.2038742151070467
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0054430929999999995	0.2038742151070467
NAIL-PATELLA SYNDROME	0.0054275	0.20329017022003779
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0054275	0.20329017022003779
BRACHYDACTYLY TYPE A1	0.0054275	0.20329017022003779
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.005423624	0.2031449923849806
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.005420992999999999	0.2030464467492645
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.005420992999999999	0.2030464467492645
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005420992999999999	0.2030464467492645
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.005397313	0.2021594985722382
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005397313	0.2021594985722382
OPTIC PATHWAY GLIOMA	0.005397313	0.2021594985722382
MULTIPLE SULFATASE DEFICIENCY	0.005397313	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.005397313	0.2021594985722382
CHÉDIAK-HIGASHI SYNDROME	0.005397313	0.2021594985722382
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005397313	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.005397313	0.2021594985722382
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.005397313	0.2021594985722382
TAY-SACHS DISEASE	0.005397313	0.2021594985722382
CANAVAN DISEASE	0.005397313	0.2021594985722382
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005397313	0.2021594985722382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.005397313	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.005397313	0.2021594985722382
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.005397313	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005397313	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.005397313	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005397313	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.005397313	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.005397313	0.2021594985722382
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.005397313	0.2021594985722382
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.005397313	0.2021594985722382
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.005397313	0.2021594985722382
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.005397313	0.2021594985722382
HSD10 DISEASE	0.005397313	0.2021594985722382
SCHINDLER DISEASE, TYPE I	0.005397313	0.2021594985722382
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.005397313	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005397313	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005397313	0.2021594985722382
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.005397313	0.2021594985722382
%300712 CRANIOFACIOSKELETAL SYNDROME	0.005319534000000001	0.19924624087540832
TRISOMY 9P	0.005319534000000001	0.19924624087540832
TEMTAMY SYNDROME	0.005319534000000001	0.19924624087540832
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.005319534000000001	0.19924624087540832
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.005319534	0.19924624087540826
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.005319534	0.19924624087540826
GENITOPATELLAR SYNDROME; GTPTS	0.005297434	0.1984184725176261
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.005234994000000001	0.19607974599002792
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.005230859000000001	0.19592486715928453
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.005208759	0.1950970988015023
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.005208759	0.1950970988015023
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005152013	0.1929716443566739
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.0051520129999999996	0.19297164435667385
SOTOS SYNDROME	0.0051520129999999996	0.19297164435667385
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0051520129999999996	0.19297164435667385
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0051520129999999996	0.19297164435667385
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0051520129999999996	0.19297164435667385
PETTIGREW SYNDROME	0.0051520129999999996	0.19297164435667385
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0051520129999999996	0.19297164435667385
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0051520129999999996	0.19297164435667385
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0051520129999999996	0.19297164435667385
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.0051520129999999996	0.19297164435667385
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0051520129999999996	0.19297164435667385
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0051520129999999996	0.19297164435667385
6Q16 MICRODELETION SYNDROME	0.004901674	0.18359505146441887
14Q22Q23 MICRODELETION SYNDROME	0.004901674	0.18359505146441887
DISTAL MONOSOMY 3P	0.004897539	0.18344017263367546
MILLER-DIEKER SYNDROME	0.004897539	0.18344017263367546
RENPENNING SYNDROME	0.004897539	0.18344017263367546
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.004879573999999999	0.18276728310663665
ROTHMUND-THOMSON SYNDROME	0.004879573999999999	0.18276728310663665
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004879573999999999	0.18276728310663665
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004875439	0.18261240427589326
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.004875439	0.18261240427589326
MARDEN-WALKER SYNDROME	0.004875439	0.18261240427589326
CHROMOSOME 18Q DELETION SYNDROME	0.004875439	0.18261240427589326
HYPERMANGANESEMIA WITH DYSTONIA 2	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.18188033492961034
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.004855894	0.18188033492961034
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.004855894	0.18188033492961034
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.004855894	0.18188033492961034
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.004855894	0.18188033492961034
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.004851759000000001	0.18172545609886695
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.004851759000000001	0.18172545609886695
MENKES DISEASE	0.004851759000000001	0.18172545609886695
CADASIL	0.004851759000000001	0.18172545609886695
FAMILIAL COLORECTAL CANCER TYPE X	0.004851759000000001	0.18172545609886695
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.18172545609886695
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.004851759000000001	0.18172545609886695
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.004851759000000001	0.18172545609886695
XERODERMA PIGMENTOSUM	0.004851759000000001	0.18172545609886695
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004851759000000001	0.18172545609886695
ASPARTYLGLUCOSAMINURIA; AGU	0.004851759000000001	0.18172545609886695
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.004851759000000001	0.18172545609886695
NASU-HAKOLA DISEASE	0.004851759000000001	0.18172545609886695
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.004851759000000001	0.18172545609886695
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004851759000000001	0.18172545609886695
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.004851759000000001	0.18172545609886695
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004851759000000001	0.18172545609886695
CHILDHOOD DISINTEGRATIVE DISORDER	0.004851759000000001	0.18172545609886695
INFANTILE NEUROAXONAL DYSTROPHY	0.004851759000000001	0.18172545609886695
LYNCH SYNDROME	0.004851759000000001	0.18172545609886695
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004851759000000001	0.18172545609886695
KRABBE DISEASE	0.004851759000000001	0.18172545609886695
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.004851759000000001	0.18172545609886695
BEHÇET DISEASE	0.004851759000000001	0.18172545609886695
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.004851759000000001	0.18172545609886695
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.004851759000000001	0.18172545609886695
METACHROMATIC LEUKODYSTROPHY	0.004851759000000001	0.18172545609886695
SNEDDON SYNDROME	0.004851759000000001	0.18172545609886695
ALEXANDER DISEASE	0.004851759000000001	0.18172545609886695
WOLFRAM SYNDROME	0.004851759000000001	0.18172545609886695
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004851759000000001	0.18172545609886695
TRIPLE A SYNDROME	0.004851759000000001	0.18172545609886695
HAND-FOOT-GENITAL SYNDROME; HFG	0.004773980000000001	0.17881219840203705
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.004773980000000001	0.17881219840203705
NOONAN SYNDROME	0.004773980000000001	0.17881219840203705
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.004773980000000001	0.17881219840203705
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.004773980000000001	0.17881219840203705
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.004773980000000001	0.17881219840203705
BANKI SYNDROME	0.004773980000000001	0.17881219840203705
WEYERS ACROFACIAL DYSOSTOSIS	0.004773980000000001	0.17881219840203705
ROIFMAN SYNDROME	0.004773980000000001	0.17881219840203705
TETRALOGY OF FALLOT	0.004773980000000001	0.17881219840203705
CLEIDOCRANIAL DYSPLASIA	0.004773980000000001	0.17881219840203705
PERIPHERAL DYSOSTOSIS	0.004773980000000001	0.17881219840203705
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.004773980000000001	0.17881219840203705
PROXIMAL SYMPHALANGISM	0.004773980000000001	0.17881219840203705
MESOMELIA-SYNOSTOSES SYNDROME	0.004773980000000001	0.17881219840203705
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.004773980000000001	0.17881219840203705
FEINGOLD SYNDROME	0.004773980000000001	0.17881219840203705
DESBUQUOIS DYSPLASIA 1	0.00475188	0.17798443004425482
ATELOSTEOGENESIS TYPE I	0.00475188	0.17798443004425482
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00475188	0.17798443004425482
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00475188	0.17798443004425482
CARPENTER SYNDROME	0.00475188	0.17798443004425482
MULTIPLE SYNOSTOSES SYNDROME 2	0.00475188	0.17798443004425482
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00475188	0.17798443004425482
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00475188	0.17798443004425482
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00475188	0.17798443004425482
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.0046894400000000004	0.17564570351665665
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.0046894400000000004	0.17564570351665665
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0046894400000000004	0.17564570351665665
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0046894400000000004	0.17564570351665665
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0046894400000000004	0.17564570351665665
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004682933	0.17540198004588342
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004682933	0.17540198004588342
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004682933	0.17540198004588342
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004682933	0.17540198004588342
8P23.1 MICRODELETION SYNDROME	0.004682933	0.17540198004588342
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004682933	0.17540198004588342
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.004682933	0.17540198004588342
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004682933	0.17540198004588342
20P12.3 MICRODELETION SYNDROME	0.004682933	0.17540198004588342
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004682933	0.17540198004588342
OCULOECTODERMAL SYNDROME; OES	0.004682933	0.17540198004588342
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00466734	0.17481793515887445
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.004610594	0.17269248071404603
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.004610594	0.17269248071404603
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.004610594	0.17269248071404603
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.004610594	0.17269248071404603
MENTAL RETARDATION, X-LINKED 99	0.004610594	0.17269248071404603
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.004610594	0.17269248071404603
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.004610594	0.17269248071404603
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.004610594	0.17269248071404603
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.004610594	0.17269248071404603
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.004610594	0.17269248071404603
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004610594	0.17269248071404603
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004610594	0.17269248071404603
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.004606459	0.17253760188330264
CLARK-BARAITSER SYNDROME	0.004606459	0.17253760188330264
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004606459	0.17253760188330264
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.004606459	0.17253760188330264
ATKIN-FLAITZ SYNDROME	0.004606459	0.17253760188330264
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.004606459	0.17253760188330264
NOONAN SYNDROME 7; NS7	0.004606459	0.17253760188330264
AICA-RIBOSIDURIA	0.004606459	0.17253760188330264
TRISOMY 8Q	0.004559374	0.17077400581424496
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004559374	0.17077400581424496
ELSAHY-WATERS SYNDROME; ESWS	0.004559374	0.17077400581424496
AYME-GRIPP SYNDROME; AYGRP	0.004555239	0.17061912698350157
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555239	0.17061912698350157
MONOSOMY 22	0.00435612	0.1631610089910476
KEIPERT SYNDROME	0.00435612	0.1631610089910476
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00435612	0.1631610089910476
WHITE FORELOCK WITH MALFORMATIONS	0.00435612	0.1631610089910476
PENOSCROTAL TRANSPOSITION	0.00435612	0.1631610089910476
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00435612	0.1631610089910476
FRAXE INTELLECTUAL DISABILITY	0.00435612	0.1631610089910476
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.004334019999999999	0.1623332406332654
MARTSOLF SYNDROME	0.004334019999999999	0.1623332406332654
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.004334019999999999	0.1623332406332654
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.004334019999999999	0.1623332406332654
HYPERTELORISM AND TETRALOGY OF FALLOT	0.004334019999999999	0.1623332406332654
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004333723	0.1623221163254708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.004333723	0.1623221163254708
GM2-GANGLIOSIDOSIS, AB VARIANT	0.004333723	0.1623221163254708
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.004333723	0.1623221163254708
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004333723	0.1623221163254708
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.004333723	0.1623221163254708
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.004333723	0.1623221163254708
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.004333723	0.1623221163254708
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.004333723	0.1623221163254708
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.004333723	0.1623221163254708
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.004333723	0.1623221163254708
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004333723	0.1623221163254708
NIEMANN-PICK DISEASE, TYPE C2	0.004333723	0.1623221163254708
PROPIONIC ACIDEMIA	0.004333723	0.1623221163254708
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.004333723	0.1623221163254708
LEIGH SYNDROME; LS	0.004333723	0.1623221163254708
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.004333723	0.1623221163254708
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.004333723	0.1623221163254708
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004333723	0.1623221163254708
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.004333723	0.1623221163254708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.004333723	0.1623221163254708
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.004333723	0.1623221163254708
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.004333723	0.1623221163254708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.004333723	0.1623221163254708
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.004333723	0.1623221163254708
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.004333723	0.1623221163254708
PELIZAEUS-MERZBACHER DISEASE	0.004333723	0.1623221163254708
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.004333723	0.1623221163254708
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.004333723	0.1623221163254708
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004333723	0.1623221163254708
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004333723	0.1623221163254708
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.004333723	0.1623221163254708
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.004333723	0.1623221163254708
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.004333723	0.1623221163254708
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.004333723	0.1623221163254708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004333723	0.1623221163254708
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004333723	0.1623221163254708
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.004333723	0.1623221163254708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004333723	0.1623221163254708
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.004333723	0.1623221163254708
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.004333723	0.1623221163254708
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.004333723	0.1623221163254708
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.004333723	0.1623221163254708
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.004333723	0.1623221163254708
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.004333723	0.1623221163254708
REFSUM DISEASE	0.00431034	0.1614462924562391
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.1614462924562391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.1614462924562391
PANDAS	0.00431034	0.1614462924562391
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.1614462924562391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.1614462924562391
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.1614462924562391
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.1614462924562391
TRISOMY 5P	0.00431034	0.1614462924562391
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.1614462924562391
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.1614462924562391
DYSOSTEOSCLEROSIS	0.00431034	0.1614462924562391
CODAS SYNDROME	0.004226054	0.15828931128863594
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004226054	0.15828931128863594
BARATELA-SCOTT SYNDROME	0.004226054	0.15828931128863594
PSEUDOAMINOPTERIN SYNDROME	0.004226054	0.15828931128863594
PHENOBARBITAL EMBRYOPATHY	0.004226054	0.15828931128863594
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004221918999999999	0.15813443245789252
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.004221918999999999	0.15813443245789252
JOUBERT SYNDROME 10	0.004141514000000001	0.15512281640325556
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.004141514000000001	0.15512281640325556
COHEN-GIBSON SYNDROME; COGIS	0.004141514000000001	0.15512281640325556
NOONAN SYNDROME 6; NS6	0.004141514000000001	0.15512281640325556
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004141514000000001	0.15512281640325556
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.004141514000000001	0.15512281640325556
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.004141514000000001	0.15512281640325556
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.004141514000000001	0.15512281640325556
8Q12 MICRODUPLICATION SYNDROME	0.004141514	0.15512281640325556
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.004137379	0.15496793757251215
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.004137379	0.15496793757251215
MOWAT-WILSON SYNDROME	0.004137379	0.15496793757251215
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.004137379	0.15496793757251215
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00406504	0.15225843824067478
MARSHALL-SMITH SYNDROME	0.00406504	0.15225843824067478
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00406504	0.15225843824067478
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00406504	0.15225843824067478
TETRASOMY 12P	0.00406504	0.15225843824067478
MARSHALL-SMITH SYNDROME; MRSHSS	0.00406504	0.15225843824067478
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00406504	0.15225843824067478
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00406504	0.15225843824067478
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00406504	0.15225843824067478
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00406504	0.15225843824067478
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00406504	0.15225843824067478
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00406504	0.15225843824067478
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00406504	0.15225843824067478
TRICHOHEPATOENTERIC SYNDROME 2	0.00406504	0.15225843824067478
OSTEOGENESIS IMPERFECTA, TYPE X	0.00406504	0.15225843824067478
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00406504	0.15225843824067478
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00406504	0.15225843824067478
MENTAL RETARDATION, X-LINKED 93	0.00406504	0.15225843824067478
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00406504	0.15225843824067478
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00406504	0.15225843824067478
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00406504	0.15225843824067478
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00406504	0.15225843824067478
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00406504	0.15225843824067478
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00406504	0.15225843824067478
FG SYNDROME 2; FGS2	0.00406504	0.15225843824067478
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00406504	0.15225843824067478
MENTAL RETARDATION, X-LINKED 19	0.00406504	0.15225843824067478
CHARLIE M SYNDROME	0.0040138199999999995	0.15033996334087368
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0040138199999999995	0.15033996334087368
GENITOPALATOCARDIAC SYNDROME	0.0040138199999999995	0.15033996334087368
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.15033996334087368
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.0040138199999999995	0.15033996334087368
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.15033996334087368
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0040138199999999995	0.15033996334087368
BASAL CELL NEVUS SYNDROME	0.0040138199999999995	0.15033996334087368
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.15033996334087368
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0040138199999999995	0.15033996334087368
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.0040138199999999995	0.15033996334087368
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0040138199999999995	0.15033996334087368
608028 THAI SYMPHALANGISM SYNDROME	0.0040138199999999995	0.15033996334087368
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.15033996334087368
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.15033996334087368
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.15033996334087368
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.15033996334087368
ACROOSTEOLYSIS DOMINANT TYPE	0.0040138199999999995	0.15033996334087368
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0040138199999999995	0.15033996334087368
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.15033996334087368
RECOMBINANT 8 SYNDROME	0.003811773	0.14277217540490908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.003811773	0.14277217540490908
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.003811773	0.14277217540490908
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.003811773	0.14277217540490908
CHROMOSOME 16P13.2 DELETION SYNDROME	0.003811773	0.14277217540490908
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.003811773	0.14277217540490908
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.003811773	0.14277217540490908
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.003811773	0.14277217540490908
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.003811773	0.14277217540490908
DPAGT1-CDG	0.003811773	0.14277217540490908
RECOMBINANT CHROMOSOME 8 SYNDROME	0.003811773	0.14277217540490908
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003792304	0.14204295268284295
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.003792304	0.14204295268284295
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.003792304	0.14204295268284295
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.003792304	0.14204295268284295
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003792304	0.14204295268284295
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.003792304	0.14204295268284295
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.003792304	0.14204295268284295
BRAIN-LUNG-THYROID SYNDROME	0.003792304	0.14204295268284295
NAVAJO NEUROHEPATOPATHY	0.003792304	0.14204295268284295
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003792304	0.14204295268284295
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.003792304	0.14204295268284295
MUCOLIPIDOSIS IV; ML4	0.003792304	0.14204295268284295
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.003792304	0.14204295268284295
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.003792304	0.14204295268284295
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.003792304	0.14204295268284295
HYPEREKPLEXIA 4; HKPX4	0.003789673	0.1419444070471269
LISSENCEPHALY 8; LIS8	0.0037896729999999995	0.14194440704712688
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0037896729999999995	0.14194440704712688
GLASS SYNDROME	0.0037896729999999995	0.14194440704712688
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.0037896729999999995	0.14194440704712688
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0037896729999999995	0.14194440704712688
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0037896729999999995	0.14194440704712688
GENITOPATELLAR SYNDROME	0.0037896729999999995	0.14194440704712688
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.0037896729999999995	0.14194440704712688
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0037896729999999995	0.14194440704712688
MIRAGE SYNDROME; MIRAGE	0.0037896729999999995	0.14194440704712688
ACROMELIC FRONTONASAL DYSPLASIA	0.0037896729999999995	0.14194440704712688
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.003788169	0.14188807385209953
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.003788169	0.14188807385209953
ATYPICAL JUVENILE PARKINSONISM	0.003788169	0.14188807385209953
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003788169	0.14188807385209953
GLUTARIC ACIDEMIA I; GA1	0.003788169	0.14188807385209953
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.003788169	0.14188807385209953
HUNTINGTON DISEASE-LIKE 3	0.003788169	0.14188807385209953
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.003788169	0.14188807385209953
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.003788169	0.14188807385209953
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.003788169	0.14188807385209953
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.003788169	0.14188807385209953
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.003788169	0.14188807385209953
LIPOID PROTEINOSIS	0.003788169	0.14188807385209953
ALZHEIMER DISEASE 3; AD	0.003788169	0.14188807385209953
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.003788169	0.14188807385209953
JUVENILE HUNTINGTON DISEASE	0.003788169	0.14188807385209953
METACHROMATIC LEUKODYSTROPHY	0.003788169	0.14188807385209953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.003788169	0.14188807385209953
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.003788169	0.14188807385209953
MERCURY POISONING	0.003788169	0.14188807385209953
LAURENCE-MOON SYNDROME	0.0036804999999999997	0.13785526881526466
SILLENCE SYNDROME	0.0036804999999999997	0.13785526881526466
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0036804999999999997	0.13785526881526466
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0036804999999999997	0.13785526881526466
DISTAL TRISOMY 5Q	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0036804999999999997	0.13785526881526466
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0036804999999999997	0.13785526881526466
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0036804999999999997	0.13785526881526466
ABRUZZO-ERICKSON SYNDROME	0.0036804999999999997	0.13785526881526466
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0036804999999999997	0.13785526881526466
16P12.1P12.3 TRIPLICATION SYNDROME	0.0036804999999999997	0.13785526881526466
ACROCEPHALOPOLYDACTYLY	0.0036804999999999997	0.13785526881526466
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00359596	0.1346887739298843
RING CHROMOSOME 13 SYNDROME	0.00359596	0.1346887739298843
FEINGOLD SYNDROME 1; FGLDS1	0.00359596	0.1346887739298843
600736 VELOFACIOSKELETAL SYNDROME	0.00359596	0.1346887739298843
SCARF SYNDROME	0.00359596	0.1346887739298843
OMODYSPLASIA 1; OMOD1	0.00359596	0.1346887739298843
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00359596	0.1346887739298843
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00359596	0.1346887739298843
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00359596	0.1346887739298843
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00359596	0.1346887739298843
RING CHROMOSOME 6 SYNDROME	0.00359596	0.1346887739298843
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00359596	0.1346887739298843
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00359596	0.1346887739298843
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00359596	0.1346887739298843
JOUBERT SYNDROME 3; JBTS3	0.00359596	0.1346887739298843
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00359596	0.1346887739298843
SHPRINTZEN OMPHALOCELE SYNDROME	0.00359596	0.1346887739298843
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032703540000000005	0.12249301176228125
12Q14 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228125
3Q29 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228125
OCULOFACIOCARDIODENTAL SYNDROME	0.0032703540000000005	0.12249301176228125
17P13.3 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.12249301176228125
POPOV-CHANG SYNDROME; POPCHAS	0.0032703540000000005	0.12249301176228125
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.0032703540000000005	0.12249301176228125
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0032703540000000005	0.12249301176228125
CHAR SYNDROME	0.0032703540000000005	0.12249301176228125
EAR-PATELLA-SHORT STATURE SYNDROME	0.0032703540000000005	0.12249301176228125
BRANCHIOOCULOFACIAL SYNDROME	0.0032662190000000003	0.12233813293153785
WARBURG MICRO SYNDROME 3; WARBM3	0.0032662190000000003	0.12233813293153785
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.0032662190000000003	0.12233813293153785
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.0032662190000000003	0.12233813293153785
CORNELIA DE LANGE SYNDROME 1	0.0032662190000000003	0.12233813293153785
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0032662190000000003	0.12233813293153785
MICROPHTHALMIA, LENZ TYPE	0.0032662190000000003	0.12233813293153785
JOUBERT SYNDROME 24	0.003248254	0.12166524340449904
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.003248254	0.12166524340449904
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.003248254	0.12166524340449904
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003248254	0.12166524340449904
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.003248254	0.12166524340449904
RICHARDS-RUNDLE SYNDROME; RRNS	0.003248254	0.12166524340449904
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003248254	0.12166524340449904
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.003248254	0.12166524340449904
WEAVER SYNDROME	0.003248254	0.12166524340449904
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.003248254	0.12166524340449904
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.003248254	0.12166524340449904
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.003248254	0.12166524340449904
RAHMAN SYNDROME	0.003248254	0.12166524340449904
ATELOSTEOGENESIS TYPE III	0.003248254	0.12166524340449904
SECKEL SYNDROME 9; SCKL9	0.003248254	0.12166524340449904
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.003248254	0.12166524340449904
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.003248254	0.12166524340449904
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.003248254	0.12166524340449904
MANGANESE POISONING	0.00324675	0.1216089102094717
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00324675	0.1216089102094717
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00324675	0.1216089102094717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00324675	0.1216089102094717
SPINOCEREBELLAR ATAXIA TYPE 8	0.00324675	0.1216089102094717
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00324675	0.1216089102094717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00324675	0.1216089102094717
WOODHOUSE-SAKATI SYNDROME	0.00324675	0.1216089102094717
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00324675	0.1216089102094717
PARKINSON DISEASE, LATE-ONSET; PD	0.00324675	0.1216089102094717
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00324675	0.1216089102094717
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00324675	0.1216089102094717
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00324675	0.1216089102094717
MACHADO-JOSEPH DISEASE; MJD	0.00324675	0.1216089102094717
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00324675	0.1216089102094717
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.00324675	0.1216089102094717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00324675	0.1216089102094717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00324675	0.1216089102094717
FRIEDREICH ATAXIA	0.00324675	0.1216089102094717
SPINOCEREBELLAR ATAXIA TYPE 11	0.00324675	0.1216089102094717
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION	0.00324675	0.1216089102094717
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00324675	0.1216089102094717
EPISODIC ATAXIA, TYPE 2	0.00324675	0.1216089102094717
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00324675	0.1216089102094717
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.00324675	0.1216089102094717
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00324675	0.1216089102094717
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00324675	0.1216089102094717
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00324675	0.1216089102094717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00324675	0.1216089102094717
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00324675	0.1216089102094717
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.00324675	0.1216089102094717
HUNTINGTON DISEASE-LIKE 2	0.00324675	0.1216089102094717
224550 DYSTONIA WITH RINGBINDEN	0.00324675	0.1216089102094717
MACHADO-JOSEPH DISEASE TYPE 3	0.00324675	0.1216089102094717
MACHADO-JOSEPH DISEASE TYPE 2	0.00324675	0.1216089102094717
MACHADO-JOSEPH DISEASE TYPE 1	0.00324675	0.1216089102094717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00324675	0.1216089102094717
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.00324675	0.1216089102094717
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.00324675	0.1216089102094717
HUNTINGTON DISEASE-LIKE 2	0.00324675	0.1216089102094717
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00324675	0.1216089102094717
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00324675	0.1216089102094717
YOUNG-ONSET PARKINSON DISEASE	0.00324675	0.1216089102094717
SPINOCEREBELLAR ATAXIA TYPE 3	0.00324675	0.1216089102094717
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00324675	0.1216089102094717
LEBER OPTIC ATROPHY AND DYSTONIA	0.00324675	0.1216089102094717
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00324675	0.1216089102094717
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00324675	0.1216089102094717
DYSTONIA 15, MYOCLONIC; DYT15	0.00324675	0.1216089102094717
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00324675	0.1216089102094717
CARIBBEAN PARKINSONISM	0.00324675	0.1216089102094717
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00324675	0.1216089102094717
%611031 EPISODIC KINESIGENIC DYSKINESIA 2; EKD2;;DYSTONIA 19; DYT19	0.00324675	0.1216089102094717
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00324675	0.1216089102094717
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.00324675	0.1216089102094717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00324675	0.1216089102094717
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00324675	0.1216089102094717
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00324675	0.1216089102094717
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00324675	0.1216089102094717
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.00324675	0.1216089102094717
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00324675	0.1216089102094717
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00324675	0.1216089102094717
LESCH-NYHAN SYNDROME; LNS	0.00324675	0.1216089102094717
SPINOCEREBELLAR ATAXIA TYPE 1	0.00324675	0.1216089102094717
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00324675	0.1216089102094717
WILSON DISEASE	0.00324675	0.1216089102094717
SPINOCEREBELLAR ATAXIA TYPE 2	0.00324675	0.1216089102094717
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00324675	0.1216089102094717
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00324675	0.1216089102094717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00324675	0.1216089102094717
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00324675	0.1216089102094717
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00324675	0.1216089102094717
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00324675	0.1216089102094717
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00324675	0.1216089102094717
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0032441189999999997	0.12151036457375562
CYSTATHIONINURIA	0.0032441189999999997	0.12151036457375562
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0032441189999999997	0.12151036457375562
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.0032441189999999997	0.12151036457375562
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0032441189999999997	0.12151036457375562
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0032441189999999997	0.12151036457375562
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.003136153	0.11746643522912614
COWDEN SYNDROME	0.003136153	0.11746643522912614
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0030516130000000003	0.11429994034374577
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0030516130000000003	0.11429994034374577
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0030516130000000003	0.11429994034374577
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0030516130000000003	0.11429994034374577
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.0030516130000000003	0.11429994034374577
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.003051613	0.11429994034374577
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.003051613	0.11429994034374577
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.003051613	0.11429994034374577
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.003051613	0.11429994034374577
KABUKI SYNDROME 1	0.003051613	0.11429994034374577
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.003051613	0.11429994034374577
CHROMOSOME 1P35 DELETION SYNDROME	0.003051613	0.11429994034374577
MICRO SYNDROME	0.003051613	0.11429994034374577
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.003051613	0.11429994034374577
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.003051613	0.11429994034374577
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.003051613	0.11429994034374577
3Q29 MICRODUPLICATION SYNDROME	0.003051613	0.11429994034374577
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003051613	0.11429994034374577
MOSAIC TRISOMY 14	0.003051613	0.11429994034374577
FLOATING-HARBOR SYNDROME	0.0027248000000000003	0.10205896928890999
SYNDACTYLY TYPE 5	0.0027248000000000003	0.10205896928890999
19Q13.11 MICRODELETION SYNDROME	0.0027248000000000003	0.10205896928890999
CEREBROCOSTOMANDIBULAR SYNDROME	0.0027248000000000003	0.10205896928890999
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.0027248000000000003	0.10205896928890999
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0027248000000000003	0.10205896928890999
MOLAR I REINCLUSION	0.0027248000000000003	0.10205896928890999
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928890999
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0027248000000000003	0.10205896928890999
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0027248000000000003	0.10205896928890999
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.0027248000000000003	0.10205896928890999
MOSAIC TRISOMY 8	0.0027248000000000003	0.10205896928890999
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0027248000000000003	0.10205896928890999
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0027248000000000003	0.10205896928890999
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0027248000000000003	0.10205896928890999
OSLAM SYNDROME	0.0027248000000000003	0.10205896928890999
MICROCEPHALY-CARDIOMYOPATHY	0.0027248000000000003	0.10205896928890999
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.0027248000000000003	0.10205896928890999
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.0027248000000000003	0.10205896928890999
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.0027248000000000003	0.10205896928890999
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.0027248000000000003	0.10205896928890999
HALLUX VARUS-PREAXIAL POLYSYNDACTYLY SYNDROME	0.0027248000000000003	0.10205896928890999
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928890999
CATEL-MANZKE SYNDROME	0.0027248000000000003	0.10205896928890999
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0027248000000000003	0.10205896928890999
ALAGILLE SYNDROME	0.0027248000000000003	0.10205896928890999
ANONYCHIA-MICROCEPHALY SYNDROME	0.0027248000000000003	0.10205896928890999
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.0027248000000000003	0.10205896928890999
DENTAL ANKYLOSIS	0.0027248000000000003	0.10205896928890999
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0027248000000000003	0.10205896928890999
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027248000000000003	0.10205896928890999
TALONAVICULAR COALITION	0.0027248000000000003	0.10205896928890999
WT LIMB-BLOOD SYNDROME	0.0027248000000000003	0.10205896928890999
MASA SYNDROME	0.0027248000000000003	0.10205896928890999
PELVIS-SHOULDER DYSPLASIA	0.0027248000000000003	0.10205896928890999
BOWEN-CONRADI SYNDROME	0.0027248000000000003	0.10205896928890999
DESBUQUOIS SYNDROME	0.0027248000000000003	0.10205896928890999
SYNDACTYLY TYPE 2	0.0027248000000000003	0.10205896928890999
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0027248000000000003	0.10205896928890999
HUNTER-MACDONALD SYNDROME	0.0027248000000000003	0.10205896928890999
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928890999
TETRALOGY OF FALLOT	0.0027248000000000003	0.10205896928890999
BRACHYDACTYLY TYPE A7	0.0027248000000000003	0.10205896928890999
SECKEL SYNDROME 5; SCKL5	0.0027248000000000003	0.10205896928890999
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0027248000000000003	0.10205896928890999
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.0027248000000000003	0.10205896928890999
FETAL MINOXIDIL SYNDROME	0.0027248000000000003	0.10205896928890999
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0027248000000000003	0.10205896928890999
LIMB-MAMMARY SYNDROME	0.0027248000000000003	0.10205896928890999
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0027248000000000003	0.10205896928890999
METATROPIC DYSPLASIA	0.0027248000000000003	0.10205896928890999
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.0027248000000000003	0.10205896928890999
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0027248000000000003	0.10205896928890999
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.0027248000000000003	0.10205896928890999
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0027248000000000003	0.10205896928890999
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0027248000000000003	0.10205896928890999
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928890999
BLOOM SYNDROME	0.0027248000000000003	0.10205896928890999
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0027248000000000003	0.10205896928890999
3M SYNDROME	0.0027248000000000003	0.10205896928890999
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.0027248000000000003	0.10205896928890999
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.0027248000000000003	0.10205896928890999
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.0027248000000000003	0.10205896928890999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002718293	0.10181524581813675
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002718293	0.10181524581813675
CK SYNDROME	0.002718293	0.10181524581813675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002718293	0.10181524581813675
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813675
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.10181524581813675
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.10181524581813675
DISTAL TRISOMY 17Q	0.002718293	0.10181524581813675
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002718293	0.10181524581813675
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002718293	0.10181524581813675
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002718293	0.10181524581813675
MONOSOMY 9P	0.002718293	0.10181524581813675
PEHO SYNDROME; PEHO	0.002718293	0.10181524581813675
MONOSOMY 9Q22.3	0.002718293	0.10181524581813675
22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813675
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002718293	0.10181524581813675
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002718293	0.10181524581813675
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.10181524581813675
XQ25 DUPLICATION SYNDROME	0.0027182929999999997	0.10181524581813672
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0027182929999999997	0.10181524581813672
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0027182929999999997	0.10181524581813672
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.0027182929999999997	0.10181524581813672
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0027182929999999997	0.10181524581813672
XQ25 MICRODUPLICATION SYNDROME	0.0027182929999999997	0.10181524581813672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0027182929999999997	0.10181524581813672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0027182929999999997	0.10181524581813672
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0027026999999999997	0.1012312009311278
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.0027026999999999997	0.1012312009311278
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0027026999999999997	0.1012312009311278
POPLITEAL PTERYGIUM SYNDROME	0.0027026999999999997	0.1012312009311278
CENTRAL CORE DISEASE	0.0027026999999999997	0.1012312009311278
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0027026999999999997	0.1012312009311278
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.0027026999999999997	0.1012312009311278
ABLEPHARON-MACROSTOMIA SYNDROME	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.0027026999999999997	0.1012312009311278
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0027026999999999997	0.1012312009311278
CRANE-HEISE SYNDROME	0.0027026999999999997	0.1012312009311278
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0027026999999999997	0.1012312009311278
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.0027026999999999997	0.1012312009311278
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.0027026999999999997	0.1012312009311278
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.0027026999999999997	0.1012312009311278
FIBULAR HEMIMELIA	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0027026999999999997	0.1012312009311278
CLOACAL EXSTROPHY	0.0027026999999999997	0.1012312009311278
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0027026999999999997	0.1012312009311278
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.0027026999999999997	0.1012312009311278
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0027026999999999997	0.1012312009311278
INIENCEPHALY	0.0027026999999999997	0.1012312009311278
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0027026999999999997	0.1012312009311278
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.0027026999999999997	0.1012312009311278
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0027026999999999997	0.1012312009311278
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.0027026999999999997	0.1012312009311278
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0027026999999999997	0.1012312009311278
LARYNGEAL ABDUCTOR PARALYSIS	0.0027026999999999997	0.1012312009311278
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0027026999999999997	0.1012312009311278
MELNICK-NEEDLES SYNDROME	0.0027026999999999997	0.1012312009311278
MYOPATHIC EHLERS-DANLOS SYNDROME	0.0027026999999999997	0.1012312009311278
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0027026999999999997	0.1012312009311278
ELLIS-VAN CREVELD SYNDROME	0.0027026999999999997	0.1012312009311278
MASA SYNDROME	0.0027026999999999997	0.1012312009311278
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.0027026999999999997	0.1012312009311278
BARTH SYNDROME; BTHS	0.0027026999999999997	0.1012312009311278
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.0027026999999999997	0.1012312009311278
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0027026999999999997	0.1012312009311278
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.0027026999999999997	0.1012312009311278
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0027026999999999997	0.1012312009311278
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.0027026999999999997	0.1012312009311278
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0027026999999999997	0.1012312009311278
LOEYS-DIETZ SYNDROME 3; LDS3	0.0027026999999999997	0.1012312009311278
NIEVERGELT SYNDROME	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027026999999999997	0.1012312009311278
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.0027026999999999997	0.1012312009311278
LOEYS-DIETZ SYNDROME 5	0.0027026999999999997	0.1012312009311278
MEIER-GORLIN SYNDROME 3; MGORS3	0.0027026999999999997	0.1012312009311278
LAMBERT SYNDROME	0.0027026999999999997	0.1012312009311278
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.0027026999999999997	0.1012312009311278
AMYLOIDOSIS	0.0027026999999999997	0.1012312009311278
MECKEL SYNDROME, TYPE 6; MKS6	0.0027026999999999997	0.1012312009311278
ACHONDROGENESIS TYPE 1B	0.0027026999999999997	0.1012312009311278
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0027026999999999997	0.1012312009311278
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0027026999999999997	0.1012312009311278
ISOLATED CLEFT LIP	0.0027026999999999997	0.1012312009311278
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0027026999999999997	0.1012312009311278
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.0027026999999999997	0.1012312009311278
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.0027026999999999997	0.1012312009311278
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.0027026999999999997	0.1012312009311278
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0027026999999999997	0.1012312009311278
BRUCK SYNDROME 2	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.0027026999999999997	0.1012312009311278
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0027026999999999997	0.1012312009311278
NATIVE AMERICAN MYOPATHY	0.0027026999999999997	0.1012312009311278
ERYTHEMA OF ACRAL REGIONS	0.0027026999999999997	0.1012312009311278
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.1012312009311278
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0027026999999999997	0.1012312009311278
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
BRUCK SYNDROME	0.0027026999999999997	0.1012312009311278
CAUDAL REGRESSION SEQUENCE	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027026999999999997	0.1012312009311278
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.0027026999999999997	0.1012312009311278
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.0027026999999999997	0.1012312009311278
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.0027026999999999997	0.1012312009311278
KYPHOMELIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
GIANT AXONAL NEUROPATHY	0.0027026999999999997	0.1012312009311278
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.0027026999999999997	0.1012312009311278
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0027026999999999997	0.1012312009311278
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0025947339999999996	0.09718727158649827
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.09718727158649827
AL-RAQAD SYNDROME; ARS	0.0025947339999999996	0.09718727158649827
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.09718727158649827
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0025947339999999996	0.09718727158649827
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.09718727158649827
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.09718727158649827
BARDET-BIEDL SYNDROME 1; BBS1	0.0025947339999999996	0.09718727158649827
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.09718727158649827
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.09718727158649827
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.09718727158649827
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.09718727158649827
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.09718727158649827
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.09703239275575488
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.002590599	0.09703239275575488
CRANIOSYNOSTOSIS 2	0.002590599	0.09703239275575488
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.09703239275575488
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.09703239275575488
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002590599	0.09703239275575488
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.09703239275575488
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.002590599	0.09703239275575488
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.002590599	0.09703239275575488
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.002590599	0.09703239275575488
ADAMS-OLIVER SYNDROME 5; AOS5	0.002590599	0.09703239275575488
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.002590599	0.09703239275575488
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.09402077670111793
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.09402077670111793
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0025101940000000003	0.09402077670111793
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.09402077670111793
TREACHER-COLLINS SYNDROME	0.0025101940000000003	0.09402077670111793
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0025101940000000003	0.09402077670111793
GERMAN SYNDROME	0.0025101940000000003	0.09402077670111793
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.09402077670111793
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.09402077670111793
HURLER SYNDROME	0.0025101940000000003	0.09402077670111793
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0025101940000000003	0.09402077670111793
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0025101940000000003	0.09402077670111793
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.09402077670111793
17Q24.2 MICRODELETION SYNDROME	0.002506059	0.09386589787037453
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.09386589787037453
ASPARTYLGLUCOSAMINURIA	0.002506059	0.09386589787037453
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.09386589787037453
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.09386589787037453
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.09386589787037453
ZLOTOGORA-OGUR SYNDROME	0.002506059	0.09386589787037453
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.002506059	0.09386589787037453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.002506059	0.09386589787037453
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002506059	0.09386589787037453
SIALIDOSIS TYPE 1	0.002506059	0.09386589787037453
ZIMMERMANN-LABAND SYNDROME 1	0.002506059	0.09386589787037453
FRYNS SYNDROME; FRNS	0.002506059	0.09386589787037453
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.002506059	0.09386589787037453
RING CHROMOSOME 10 SYNDROME	0.002506059	0.09386589787037453
ACROCARDIOFACIAL SYNDROME	0.002506059	0.09386589787037453
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.08153608217550888
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.08153608217550888
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021768739999999996	0.08153608217550888
LATERAL MENINGOCELE SYNDROME	0.0021768739999999996	0.08153608217550888
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.08153608217550888
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021768739999999996	0.08153608217550888
HADZISELIMOVIC SYNDROME	0.0021768739999999996	0.08153608217550888
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.08153608217550888
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.08153608217550888
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.08153608217550888
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.08153608217550888
48,XYYY SYNDROME	0.0021768739999999996	0.08153608217550888
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.08153608217550888
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.08153608217550888
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.08153608217550888
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0021768739999999996	0.08153608217550888
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021768739999999996	0.08153608217550888
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021768739999999996	0.08153608217550888
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021768739999999996	0.08153608217550888
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.08153608217550888
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.08153608217550888
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0021768739999999996	0.08153608217550888
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021768739999999996	0.08153608217550888
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.08153608217550888
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.08153608217550888
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.08153608217550888
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.08153608217550888
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021768739999999996	0.08153608217550888
ICF SYNDROME	0.0021768739999999996	0.08153608217550888
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.08153608217550888
TOLUENE EMBRYOPATHY	0.0021768739999999996	0.08153608217550888
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.08153608217550888
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.08153608217550888
JOUBERT SYNDROME 14	0.0021768739999999996	0.08153608217550888
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.08138120334476548
MOMO SYNDROME	0.002172739	0.08138120334476548
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.08138120334476548
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.08138120334476548
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.002172739	0.08138120334476548
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002172739	0.08138120334476548
TETRASOMY 18P	0.002172739	0.08138120334476548
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.07675322911312704
OPSISMODYSPLASIA	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.07675322911312704
2Q37 MONOSOMY	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00204918	0.07675322911312704
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.07675322911312704
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.07675322911312704
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.07675322911312704
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312704
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.07675322911312704
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.07675322911312704
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.07675322911312704
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.07675322911312704
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312704
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.07675322911312704
HEART-HAND SYNDROME TYPE 3	0.00204918	0.07675322911312704
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.07675322911312704
CHST3-RELATED SKELETAL DYSPLASIA	0.00204918	0.07675322911312704
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.07675322911312704
CHITAYAT SYNDROME	0.00204918	0.07675322911312704
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.07675322911312704
LERI PLEONOSTEOSIS	0.00204918	0.07675322911312704
RADIO-RENAL SYNDROME	0.00204918	0.07675322911312704
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.07675322911312704
FGFR2-RELATED BENT BONE DYSPLASIA	0.00204918	0.07675322911312704
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.07675322911312704
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.07675322911312704
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.07675322911312704
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00204918	0.07675322911312704
EIKEN SYNDROME	0.00204918	0.07675322911312704
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.07675322911312704
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.07675322911312704
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.07675322911312704
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.07675322911312704
LARON SYNDROME	0.00204918	0.07675322911312704
SMITH-MAGENIS SYNDROME	0.00204918	0.07675322911312704
SATOYOSHI SYNDROME	0.00204918	0.07675322911312704
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.07675322911312704
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.07675322911312704
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.07675322911312704
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.07675322911312704
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.07675322911312704
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.07675322911312704
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.07675322911312704
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.07675322911312704
HEART-HAND SYNDROME TYPE 2	0.00204918	0.07675322911312704
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.07675322911312704
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.07675322911312704
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.07675322911312704
EMERY-NELSON SYNDROME	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.07675322911312704
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.07675322911312704
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.07675322911312704
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.07675322911312704
ACROMICRIC DYSPLASIA	0.00204918	0.07675322911312704
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.07675322911312704
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.07675322911312704
GREENBERG DYSPLASIA	0.00204918	0.07675322911312704
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.07675322911312704
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.07675322911312704
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00204918	0.07675322911312704
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.07675322911312704
PYCNODYSOSTOSIS	0.00204918	0.07675322911312704
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.07675322911312704
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.07675322911312704
METATROPIC DYSPLASIA	0.00204918	0.07675322911312704
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.07675322911312704
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.07675322911312704
INFANTILE SYSTEMIC HYALINOSIS	0.00204918	0.07675322911312704
RIN2 SYNDROME	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.07675322911312704
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.07675322911312704
MAL DE MELEDA	0.00204918	0.07675322911312704
COOKS SYNDROME	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.07675322911312704
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.07675322911312704
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.07675322911312704
ENG-STROM SYNDROME	0.00204918	0.07675322911312704
ISOLATED BRACHYCEPHALY	0.00204918	0.07675322911312704
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.07675322911312704
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.07675322911312704
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.07675322911312704
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.07675322911312704
SYMPHALANGISM, DISTAL	0.00204918	0.07675322911312704
SYNDACTYLY, TYPE V	0.00204918	0.07675322911312704
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.07675322911312704
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00204918	0.07675322911312704
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.07675322911312704
RHYNS SYNDROME; RHYNS	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.07675322911312704
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.07675322911312704
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.07675322911312704
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.07675322911312704
PSEUDOACHONDROPLASIA	0.00204918	0.07675322911312704
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.07675322911312704
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.07675322911312704
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.07675322911312704
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.07675322911312704
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.07675322911312704
LOWRY-WOOD SYNDROME	0.00204918	0.07675322911312704
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.07675322911312704
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.07675322911312704
MACS SYNDROME	0.00204918	0.07675322911312704
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00196464	0.07358673422774667
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00196464	0.07358673422774667
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.07358673422774667
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774667
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774667
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.07358673422774667
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.07358673422774667
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00196464	0.07358673422774667
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.07358673422774667
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00196464	0.07358673422774667
FRONTOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774667
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.07358673422774667
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.07358673422774667
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.07358673422774667
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00196464	0.07358673422774667
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.07358673422774667
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.07358673422774667
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.07358673422774667
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774667
BOOMERANG DYSPLASIA	0.00196464	0.07358673422774667
STROMME SYNDROME; STROMS	0.00196464	0.07358673422774667
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.07358673422774667
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.07358673422774667
NEONATAL MARFAN SYNDROME	0.00196464	0.07358673422774667
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00196464	0.07358673422774667
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00196464	0.07358673422774667
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.07358673422774667
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774667
WAARDENBURG-SHAH SYNDROME	0.00196464	0.07358673422774667
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.07358673422774667
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00196464	0.07358673422774667
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.07358673422774667
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.07358673422774667
MULIBREY NANISM	0.00196464	0.07358673422774667
MEGALENCEPHALY	0.00196464	0.07358673422774667
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.07358673422774667
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774667
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00196464	0.07358673422774667
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.07358673422774667
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00196464	0.07358673422774667
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.07358673422774667
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00196464	0.07358673422774667
MARSHALL SYNDROME	0.00196464	0.07358673422774667
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.07358673422774667
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00196464	0.07358673422774667
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00196464	0.07358673422774667
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774667
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.07358673422774667
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774667
WAARDENBURG SYNDROME	0.00196464	0.07358673422774667
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00196464	0.07358673422774667
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.07358673422774667
ISOLATED TRIGONOCEPHALY	0.00196464	0.07358673422774667
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774667
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.07358673422774667
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.07358673422774667
ADULT SYNDROME	0.00196464	0.07358673422774667
OTOPALATODIGITAL SYNDROME TYPE 1	0.00196464	0.07358673422774667
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00196464	0.07358673422774667
RETINITIS PIGMENTOSA	0.00196464	0.07358673422774667
MILROY DISEASE	0.00163132	0.06110203970213764
LEGIUS SYNDROME	0.00163132	0.06110203970213764
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.06110203970213764
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.06110203970213764
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.06110203970213764
BRITTLE CORNEA SYNDROME	0.00163132	0.06110203970213764
PHAVER SYNDROME	0.00163132	0.06110203970213764
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.06110203970213764
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213764
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.06110203970213764
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00163132	0.06110203970213764
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.06110203970213764
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.06110203970213764
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.06110203970213764
JUBERG-MARSIDI SYNDROME	0.00163132	0.06110203970213764
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00163132	0.06110203970213764
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.06110203970213764
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.06110203970213764
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.06110203970213764
FETAL VALPROATE SYNDROME	0.00163132	0.06110203970213764
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.06110203970213764
SCARF SYNDROME	0.00163132	0.06110203970213764
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.06110203970213764
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.06110203970213764
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213764
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.06110203970213764
BALLER-GEROLD SYNDROME	0.00163132	0.06110203970213764
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.06110203970213764
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.06110203970213764
MYOTONIA PERMANENS	0.00163132	0.06110203970213764
SCHOLTE SYNDROME; SHLTS	0.00163132	0.06110203970213764
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.06110203970213764
COSTELLO SYNDROME	0.00163132	0.06110203970213764
EPICANTHUS	0.00163132	0.06110203970213764
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.06110203970213764
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.06110203970213764
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.06110203970213764
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.06110203970213764
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.06110203970213764
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.06110203970213764
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.06110203970213764
NOONAN SYNDROME 8; NS8	0.00163132	0.06110203970213764
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.06110203970213764
LICHTENSTEIN SYNDROME	0.00163132	0.06110203970213764
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.06110203970213764
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.06110203970213764
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.06110203970213764
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.06110203970213764
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.06110203970213764
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.06110203970213764
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.06110203970213764
STICKLER SYNDROME	0.00163132	0.06110203970213764
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.06110203970213764
PTERYGIUM COLLI, ISOLATED	0.00163132	0.06110203970213764
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.06110203970213764
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.06110203970213764
PALLISTER-HALL SYNDROME	0.001086973	0.0407132061159991
CRANIOPHARYNGIOMA	0.001086973	0.0407132061159991
INFANTILE REFSUM DISEASE	0.001086973	0.0407132061159991
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.0407132061159991
GRISCELLI SYNDROME	0.001086973	0.0407132061159991
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.0407132061159991
WYBURN-MASON SYNDROME	0.001086973	0.0407132061159991
MEND SYNDROME	0.001086973	0.0407132061159991
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.0407132061159991
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.0407132061159991
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.0407132061159991
ISOVALERIC ACIDEMIA	0.001086973	0.0407132061159991
HARTNUP DISORDER	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.0407132061159991
ARGININOSUCCINIC ACIDURIA	0.001086973	0.0407132061159991
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.0407132061159991
XQ28 (MECP2) DUPLICATION	0.001086973	0.0407132061159991
COACH SYNDROME	0.001086973	0.0407132061159991
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.0407132061159991
ANGELMAN SYNDROME	0.001086973	0.0407132061159991
ELEJALDE DISEASE	0.001086973	0.0407132061159991
MAPLE SYRUP URINE DISEASE	0.001086973	0.0407132061159991
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.0407132061159991
SSR4-CDG	0.001086973	0.0407132061159991
WILSON-TURNER SYNDROME	0.001086973	0.0407132061159991
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.0407132061159991
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.0407132061159991
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.0407132061159991
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.0407132061159991
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.0407132061159991
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.0407132061159991
CLASSIC PHENYLKETONURIA	0.001086973	0.0407132061159991
MACDERMOT-WINTER SYNDROME	0.001086973	0.0407132061159991
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.0407132061159991
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.0407132061159991
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.0407132061159991
NARP SYNDROME	0.001086973	0.0407132061159991
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.0407132061159991
STT3B-CDG	0.001086973	0.0407132061159991
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.0407132061159991
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.0407132061159991
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.0407132061159991
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.0407132061159991
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
NETHERTON SYNDROME	0.001086973	0.0407132061159991
DYSTONIA-APHONIA SYNDROME	0.001086973	0.0407132061159991
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.0407132061159991
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.0407132061159991
GALACTOSEMIA	0.001086973	0.0407132061159991
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.0407132061159991
LANDAU-KLEFFNER SYNDROME	0.001086973	0.0407132061159991
LEBER CONGENITAL AMAUROSIS	0.001086973	0.0407132061159991
SEVERE CANAVAN DISEASE	0.001086973	0.0407132061159991
STT3A-CDG	0.001086973	0.0407132061159991
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.0407132061159991
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.0407132061159991
GAUCHER DISEASE, TYPE II	0.001086973	0.0407132061159991
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.0407132061159991
SULFOCYSTEINURIA	0.001086973	0.0407132061159991
DISTAL MONOSOMY 19P13.3	0.001086973	0.0407132061159991
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.0407132061159991
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.0407132061159991
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.0407132061159991
CEDNIK SYNDROME	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.0407132061159991
VICI SYNDROME; VICIS	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.0407132061159991
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.0407132061159991
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.0407132061159991
KETOADIPICACIDURIA	0.001086973	0.0407132061159991
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.0407132061159991
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.0407132061159991
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.0407132061159991
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.0407132061159991
CITRULLINEMIA, CLASSIC	0.001086973	0.0407132061159991
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.0407132061159991
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.0407132061159991
XQ21 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.0407132061159991
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.0407132061159991
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.0407132061159991
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.0407132061159991
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.0407132061159991
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.0407132061159991
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.0407132061159991
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.0407132061159991
VICI SYNDROME	0.001086973	0.0407132061159991
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.0407132061159991
KEUTEL SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.0407132061159991
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.0407132061159991
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.0407132061159991
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.0407132061159991
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.0407132061159991
LISSENCEPHALY 4	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.0407132061159991
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.0407132061159991
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.0407132061159991
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.0407132061159991
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.0407132061159991
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.0407132061159991
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001086973	0.0407132061159991
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.0407132061159991
2P21 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.0407132061159991
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 7	0.001086973	0.0407132061159991
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.0407132061159991
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.0407132061159991
HARTNUP DISEASE	0.001086973	0.0407132061159991
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.0407132061159991
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.0407132061159991
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.0407132061159991
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.0407132061159991
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.0407132061159991
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.0407132061159991
HYDRANENCEPHALY	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.0407132061159991
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.0407132061159991
EMANUEL SYNDROME	0.001086973	0.0407132061159991
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.0407132061159991
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.0407132061159991
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.0407132061159991
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.0407132061159991
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.0407132061159991
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.0407132061159991
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.0407132061159991
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.0407132061159991
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.0407132061159991
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.0407132061159991
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.0407132061159991
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.0407132061159991
EAST SYNDROME	0.001086973	0.0407132061159991
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.0407132061159991
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.0407132061159991
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.0407132061159991
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.0407132061159991
PFEIFFER SYNDROME TYPE 2	0.001086973	0.0407132061159991
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.0407132061159991
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.0407132061159991
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.0407132061159991
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.0407132061159991
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.0407132061159991
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.0407132061159991
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.0407132061159991
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.0407132061159991
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.0407132061159991
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.0407132061159991
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.0407132061159991
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.0407132061159991
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.0407132061159991
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.0407132061159991
ARGININEMIA	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.0407132061159991
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.0407132061159991
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 5	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.0407132061159991
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.0407132061159991
WALKER-WARBURG SYNDROME	0.001086973	0.0407132061159991
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.0407132061159991
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.0407132061159991
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.0407132061159991
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.0407132061159991
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.0407132061159991
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.0407132061159991
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.0407132061159991
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.0407132061159991
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.0407132061159991
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.0407132061159991
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.0407132061159991
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.0407132061159991
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.0407132061159991
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.0407132061159991
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.0407132061159991
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.0407132061159991
SIALIDOSIS TYPE 2	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.0407132061159991
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.0407132061159991
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.0407132061159991
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.0407132061159991
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.0407132061159991
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.0407132061159991
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.0407132061159991
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.0407132061159991
LISSENCEPHALY 1; LIS1	0.001086973	0.0407132061159991
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.0407132061159991
ALG3-CDG	0.001086973	0.0407132061159991
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.0407132061159991
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.0407132061159991
15Q14 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.0407132061159991
CITRULLINEMIA TYPE II	0.001086973	0.0407132061159991
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.0407132061159991
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.0407132061159991
L1 SYNDROME	0.001086973	0.0407132061159991
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.0407132061159991
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.0407132061159991
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.0407132061159991
PHACE ASSOCIATION	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.0407132061159991
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.0407132061159991
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.0407132061159991
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.0407132061159991
SALLA DISEASE	0.001086973	0.0407132061159991
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.0407132061159991
MEVALONIC ACIDURIA	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.0407132061159991
SCHIZENCEPHALY	0.001086973	0.0407132061159991
WAISMAN SYNDROME; WSMN	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.0407132061159991
MEND SYNDROME; MEND	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.0407132061159991
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.0407132061159991
RFT1-CDG	0.001086973	0.0407132061159991
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.0407132061159991
MEHMO SYNDROME; MEHMO	0.001086973	0.0407132061159991
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.0407132061159991
CODAS SYNDROME	0.001086973	0.0407132061159991
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.0407132061159991
ALG11-CDG	0.001086973	0.0407132061159991
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.0407132061159991
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.0407132061159991
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.0407132061159991
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.0407132061159991
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
ALG1-CDG	0.001086973	0.0407132061159991
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.0407132061159991
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.0407132061159991
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.0407132061159991
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.0407132061159991
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020434042473371255
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 2	0.000545554	0.020434042473371255
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020434042473371255
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.020434042473371255
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020434042473371255
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020434042473371255
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020434042473371255
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020434042473371255
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020434042473371255
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020434042473371255
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.020434042473371255
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020434042473371255
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020434042473371255
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020434042473371255
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020434042473371255
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020434042473371255
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020434042473371255
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020434042473371255
XIA-GIBBS SYNDROME	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.020434042473371255
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020434042473371255
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020434042473371255
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020434042473371255
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020434042473371255
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020434042473371255
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020434042473371255
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.020434042473371255
JOUBERT SYNDROME 21	0.000545554	0.020434042473371255
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020434042473371255
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020434042473371255
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020434042473371255
HYDROXYKYNURENINURIA	0.000545554	0.020434042473371255
NOONAN SYNDROME 11; NS11	0.000545554	0.020434042473371255
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.020434042473371255
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.020434042473371255
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020434042473371255
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.020434042473371255
FRIED SYNDROME	0.000545554	0.020434042473371255
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020434042473371255
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.020434042473371255
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020434042473371255
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020434042473371255
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.020434042473371255
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.020434042473371255
CULLER-JONES SYNDROME; CJS	0.000545554	0.020434042473371255
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020434042473371255
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020434042473371255
CURRARINO SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020434042473371255
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020434042473371255
TRANSKETOLASE DEFICIENCY	0.000545554	0.020434042473371255
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.020434042473371255
SEPTOOPTIC DYSPLASIA	0.000545554	0.020434042473371255
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020434042473371255
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020434042473371255
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.020434042473371255
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020434042473371255
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.020434042473371255
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020434042473371255
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020434042473371255
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.020434042473371255
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020434042473371255
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020434042473371255
OPTIC ATROPHY 11; OPA11	0.000545554	0.020434042473371255
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020434042473371255
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020434042473371255
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020434042473371255
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.020434042473371255
NOONAN SYNDROME 9; NS9	0.000545554	0.020434042473371255
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020434042473371255
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020434042473371255
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020434042473371255
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020434042473371255
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020434042473371255
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020434042473371255
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020434042473371255
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020434042473371255
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.020434042473371255
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020434042473371255
JOUBERT SYNDROME 25	0.000545554	0.020434042473371255
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020434042473371255
MEIER-GORLIN SYNDROME 7	0.000545554	0.020434042473371255
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020434042473371255
JOUBERT SYNDROME 27	0.000545554	0.020434042473371255
JOUBERT SYNDROME 28	0.000545554	0.020434042473371255
ALAZAMI-YUAN SYNDROME	0.000545554	0.020434042473371255
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020434042473371255
MEDULLOBLASTOMA	0.000545554	0.020434042473371255
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020434042473371255
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020434042473371255
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.020434042473371255
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020434042473371255
REVESZ SYNDROME	0.000545554	0.020434042473371255
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.020434042473371255
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020434042473371255
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020434042473371255
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020434042473371255
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020434042473371255
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020434042473371255
ALG6-CDG	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020434042473371255
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.020434042473371255
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.020434042473371255
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020434042473371255
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020434042473371255
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.020434042473371255
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020434042473371255
SENIOR-LOKEN SYNDROME	0.000545554	0.020434042473371255
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020434042473371255
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020434042473371255
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.020434042473371255
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020434042473371255
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020434042473371255
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020434042473371255
MECKEL SYNDROME 13; MKS13	0.000545554	0.020434042473371255
WOLMAN DISEASE	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020434042473371255
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020434042473371255
THYROID HEMIAGENESIS	0.000545554	0.020434042473371255
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020434042473371255
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020434042473371255
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020434042473371255
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020434042473371255
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020434042473371255
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020434042473371255
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.020434042473371255
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020434042473371255
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020434042473371255
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.020434042473371255
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020434042473371255
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020434042473371255
DISTAL TRISOMY 6P	0.000545554	0.020434042473371255
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020434042473371255
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020434042473371255
NOONAN SYNDROME 2; NS2	0.000545554	0.020434042473371255
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020434042473371255
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020434042473371255
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020434042473371255
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020434042473371255
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020434042473371255
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020434042473371255
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020434042473371255
RIGID SPINE SYNDROME	0.000545554	0.020434042473371255
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020434042473371255
JOUBERT SYNDROME 8	0.000545554	0.020434042473371255
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020434042473371255
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.020434042473371255
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020434042473371255
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020434042473371255
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020434042473371255
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020434042473371255
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020434042473371255
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020434042473371255
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020434042473371255
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020434042473371255
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.020434042473371255
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020434042473371255
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020434042473371255
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.020434042473371255
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020434042473371255
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.020434042473371255
FARBER DISEASE	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020434042473371255
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020434042473371255
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020434042473371255
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.020434042473371255
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020434042473371255
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020434042473371255
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020434042473371255
FRIAS SYNDROME	0.000545554	0.020434042473371255
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020434042473371255
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020434042473371255
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020434042473371255
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020434042473371255
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.020434042473371255
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020434042473371255
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.020434042473371255
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.020434042473371255
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020434042473371255
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020434042473371255
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020434042473371255
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.020434042473371255
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.020434042473371255
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020434042473371255
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020434042473371255
PROPIONIC ACIDEMIA	0.000545554	0.020434042473371255
YUNIS-VARON SYNDROME	0.000545554	0.020434042473371255
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020434042473371255
USHER SYNDROME TYPE 1	0.000545554	0.020434042473371255
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.020434042473371255
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020434042473371255
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.020434042473371255
JOUBERT SYNDROME 7	0.000545554	0.020434042473371255
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020434042473371255
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020434042473371255
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020434042473371255
ARIMA SYNDROME	0.000545554	0.020434042473371255
COLE-CARPENTER SYNDROME	0.000545554	0.020434042473371255
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020434042473371255
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020434042473371255
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.020434042473371255
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020434042473371255
HURLER SYNDROME	0.000545554	0.020434042473371255
JOUBERT SYNDROME 6	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.020434042473371255
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.020434042473371255
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020434042473371255
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020434042473371255
MEVALONIC ACIDURIA; MEVA	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020434042473371255
CDAGS SYNDROME	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020434042473371255
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020434042473371255
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
PELLAGRA-LIKE SYNDROME	0.000545554	0.020434042473371255
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.020434042473371255
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.020434042473371255
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.020434042473371255
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.020434042473371255
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020434042473371255
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020434042473371255
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020434042473371255
AURICULOCONDYLAR SYNDROME	0.000545554	0.020434042473371255
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020434042473371255
OROTIC ACIDURIA	0.000545554	0.020434042473371255
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.020434042473371255
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020434042473371255
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.020434042473371255
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020434042473371255
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020434042473371255
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020434042473371255
TRANSALDOLASE DEFICIENCY	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020434042473371255
LOWRY-MACLEAN SYNDROME	0.000545554	0.020434042473371255
AUSTRALIA ANTIGEN	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020434042473371255
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020434042473371255
ABETAL34V AMYLOIDOSIS	0.000545554	0.020434042473371255
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020434042473371255
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020434042473371255
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020434042473371255
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020434042473371255
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020434042473371255
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020434042473371255
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.020434042473371255
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020434042473371255
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020434042473371255
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020434042473371255
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.020434042473371255
CURRY-JONES SYNDROME	0.000545554	0.020434042473371255
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020434042473371255
HOLOPROSENCEPHALY 11	0.000545554	0.020434042473371255
JOUBERT SYNDROME 15	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020434042473371255
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020434042473371255
RIDDLE SYNDROME	0.000545554	0.020434042473371255
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020434042473371255
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020434042473371255
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020434042473371255
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020434042473371255
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.020434042473371255
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.020434042473371255
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020434042473371255
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020434042473371255
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020434042473371255
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020434042473371255
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020434042473371255
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020279163642627846
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020279163642627846
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020279163642627846
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020279163642627846
SCLERODERMA	0.000541419	0.020279163642627846
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020279163642627846
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020279163642627846
PORPHYRIA VARIEGATA	0.000541419	0.020279163642627846
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020279163642627846
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020279163642627846
HEREDITARY COPROPORPHYRIA	0.000541419	0.020279163642627846
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020279163642627846
SYSTEMIC SCLEROSIS	0.000541419	0.020279163642627846
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020279163642627846
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020279163642627846
MOGS-CDG	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020279163642627846
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020279163642627846
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020279163642627846
INSULINOMA	0.000541419	0.020279163642627846
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020279163642627846
ALG9-CDG	0.000541419	0.020279163642627846
SECONDARY SYRINGOMYELIA	0.000541419	0.020279163642627846
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020279163642627846
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020279163642627846
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020279163642627846
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020279163642627846
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020279163642627846
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020279163642627846
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020279163642627846
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020279163642627846
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020279163642627846
NIPAH VIRUS DISEASE	0.000541419	0.020279163642627846
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020279163642627846
FRAGILE X SYNDROME	0.000541419	0.020279163642627846
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020279163642627846
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.020279163642627846
ALG2-CDG	0.000541419	0.020279163642627846
MPDU1-CDG	0.000541419	0.020279163642627846
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020279163642627846
ADDISON DISEASE	0.000541419	0.020279163642627846
ENCEPHALITIS LETHARGICA	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020279163642627846
DERMOTRICHIC SYNDROME	0.000541419	0.020279163642627846
PORPHYRIA	0.000541419	0.020279163642627846
FETAL GAUCHER DISEASE	0.000541419	0.020279163642627846
PARTINGTON SYNDROME	0.000541419	0.020279163642627846
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020279163642627846
RABIES	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020279163642627846
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020279163642627846
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020279163642627846
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020279163642627846
EPISODIC ATAXIA TYPE 3	0.000541419	0.020279163642627846
SCRUB TYPHUS	0.000541419	0.020279163642627846
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020279163642627846
CAMOS SYNDROME	0.000541419	0.020279163642627846
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627846
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020279163642627846
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020279163642627846
ANGELMAN SYNDROME	0.000541419	0.020279163642627846
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020279163642627846
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020279163642627846
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020279163642627846
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020279163642627846
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020279163642627846
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020279163642627846
CYCLIC VOMITING SYNDROME	0.000541419	0.020279163642627846
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020279163642627846
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020279163642627846
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020279163642627846
GURRIERI SYNDROME	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020279163642627846
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020279163642627846
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020279163642627846
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627846
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020279163642627846
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020279163642627846
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020279163642627846
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020279163642627846
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020279163642627846
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020279163642627846
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020279163642627846
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.020279163642627846
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020279163642627846
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020279163642627846
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020279163642627846
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627846
XYLOSIDASE DEFICIENCY	0.000541419	0.020279163642627846
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020279163642627846
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020279163642627846
ADRENOLEUKODYSTROPHY	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020279163642627846
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020279163642627846
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020279163642627846
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020279163642627846
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 47	0.000541419	0.020279163642627846
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020279163642627846
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020279163642627846
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020279163642627846
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020279163642627846
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020279163642627846
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020279163642627846
PERRAULT SYNDROME 3	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020279163642627846
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.020279163642627846
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020279163642627846
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020279163642627846
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020279163642627846
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020279163642627846
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020279163642627846
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020279163642627846
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020279163642627846
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020279163642627846
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020279163642627846
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020279163642627846
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020279163642627846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020279163642627846
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020279163642627846
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020279163642627846
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020279163642627846
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020279163642627846
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020279163642627846
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020279163642627846
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020279163642627846
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020279163642627846
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020279163642627846
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020279163642627846
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020279163642627846
LISSENCEPHALY 3; LIS3	0.000541419	0.020279163642627846
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020279163642627846
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020279163642627846
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020279163642627846
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020279163642627846
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020279163642627846
THREONINEMIA	0.000541419	0.020279163642627846
TAY-SACHS DISEASE; TSD	0.000541419	0.020279163642627846
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020279163642627846
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020279163642627846
PARIETAL FORAMINA	0.000541419	0.020279163642627846
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020279163642627846
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.020279163642627846
SNEDDON SYNDROME	0.000541419	0.020279163642627846
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020279163642627846
STURGE-WEBER SYNDROME	0.000541419	0.020279163642627846
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020279163642627846
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020279163642627846
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020279163642627846
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020279163642627846
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627846
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.020279163642627846
AUTISM	0.000541419	0.020279163642627846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020279163642627846
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020279163642627846
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020279163642627846
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020279163642627846
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020279163642627846
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020279163642627846
COHEN SYNDROME	0.000541419	0.020279163642627846
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020279163642627846
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020279163642627846
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020279163642627846
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020279163642627846
1P36 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020279163642627846
2Q33.1 DELETION SYNDROME	0.000541419	0.020279163642627846
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020279163642627846
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020279163642627846
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020279163642627846
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020279163642627846
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020279163642627846
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020279163642627846
PAPILLORENAL SYNDROME	0.000541419	0.020279163642627846
CROUZON SYNDROME	0.000541419	0.020279163642627846
DARIER-WHITE DISEASE; DAR	0.000541419	0.020279163642627846
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020279163642627846
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020279163642627846
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020279163642627846
EPILEPSY, READING	0.000541419	0.020279163642627846
FLYNN-AIRD SYNDROME	0.000541419	0.020279163642627846
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020279163642627846
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020279163642627846
HUNTINGTON DISEASE; HD	0.000541419	0.020279163642627846
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020279163642627846
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020279163642627846
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020279163642627846
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020279163642627846
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020279163642627846
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020279163642627846
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020279163642627846
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020279163642627846
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020279163642627846
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020279163642627846
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.020279163642627846
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020279163642627846
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020279163642627846
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020279163642627846
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020279163642627846
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020279163642627846
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020279163642627846
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020279163642627846
NEURAMINIDASE DEFICIENCY	0.000541419	0.020279163642627846
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020279163642627846
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020279163642627846
PHENYLKETONURIA	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020279163642627846
GITELMAN SYNDROME	0.000541419	0.020279163642627846
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020279163642627846
RAMON SYNDROME	0.000541419	0.020279163642627846
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020279163642627846
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020279163642627846
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020279163642627846
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020279163642627846
DIAMINOPENTANURIA	0.000541419	0.020279163642627846
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020279163642627846
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020279163642627846
EPILEPSY-TELANGIECTASIA	0.000541419	0.020279163642627846
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020279163642627846
FOUNTAIN SYNDROME	0.000541419	0.020279163642627846
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020279163642627846
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627846
GAPO SYNDROME; GAPOS	0.000541419	0.020279163642627846
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020279163642627846
BERNARD-SOULIER SYNDROME	0.000541419	0.020279163642627846
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020279163642627846
HYPER-BETA-ALANINEMIA	0.000541419	0.020279163642627846
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020279163642627846
HYPERLYSINEMIA, TYPE I	0.000541419	0.020279163642627846
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020279163642627846
HYPERPROLINEMIA, TYPE II	0.000541419	0.020279163642627846
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020279163642627846
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020279163642627846
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020279163642627846
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020279163642627846
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020279163642627846
KAPUR-TORIELLO SYNDROME	0.000541419	0.020279163642627846
KIFAFA SEIZURE DISORDER	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020279163642627846
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020279163642627846
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020279163642627846
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020279163642627846
TYROSINEMIA TYPE 2	0.000541419	0.020279163642627846
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020279163642627846
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020279163642627846
CRONKHITE-CANADA SYNDROME	0.000541419	0.020279163642627846
PORENCEPHALY	0.000541419	0.020279163642627846
PROLACTINOMA	0.000541419	0.020279163642627846
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020279163642627846
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020279163642627846
RAMON SYNDROME	0.000541419	0.020279163642627846
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020279163642627846
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020279163642627846
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020279163642627846
NOCARDIOSIS	0.000541419	0.020279163642627846
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020279163642627846
LUJO HEMORRHAGIC FEVER	0.000541419	0.020279163642627846
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020279163642627846
RIFT VALLEY FEVER	0.000541419	0.020279163642627846
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020279163642627846
STURGE-WEBER SYNDROME	0.000541419	0.020279163642627846
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020279163642627846
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020279163642627846
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020279163642627846
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020279163642627846
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020279163642627846
KABUKI SYNDROME	0.000541419	0.020279163642627846
SANJAD-SAKATI SYNDROME	0.000541419	0.020279163642627846
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020279163642627846
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020279163642627846
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020279163642627846
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020279163642627846
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020279163642627846
EPENDYMOMA	0.000541419	0.020279163642627846
SUBEPENDYMOMA	0.000541419	0.020279163642627846
PINEOBLASTOMA	0.000541419	0.020279163642627846
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
MICROSPORIDIOSIS	0.000541419	0.020279163642627846
MOYAMOYA DISEASE	0.000541419	0.020279163642627846
MOYNAHAN SYNDROME	0.000541419	0.020279163642627846
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020279163642627846
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020279163642627846
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020279163642627846
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020279163642627846
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020279163642627846
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020279163642627846
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020279163642627846
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020279163642627846
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020279163642627846
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020279163642627846
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020279163642627846
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020279163642627846
KALLMANN SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020279163642627846
WHIM SYNDROME	0.000541419	0.020279163642627846
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020279163642627846
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020279163642627846
OCULOCEREBRORENAL SYNDROME OF LOWE	0.000541419	0.020279163642627846
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020279163642627846
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020279163642627846
MYASTHENIA GRAVIS	0.000541419	0.020279163642627846
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020279163642627846
CENTRONUCLEAR MYOPATHY	0.000541419	0.020279163642627846
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020279163642627846
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020279163642627846
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020279163642627846
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020279163642627846
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020279163642627846
ONDINE SYNDROME	0.000541419	0.020279163642627846
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020279163642627846
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020279163642627846
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020279163642627846
HYPOPHOSPHATASIA	0.000541419	0.020279163642627846
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020279163642627846
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020279163642627846
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020279163642627846
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020279163642627846
TAKAYASU ARTERITIS	0.000541419	0.020279163642627846
THYROCEREBRORENAL SYNDROME	0.000541419	0.020279163642627846
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020279163642627846
WORSTER-DROUGHT SYNDROME	0.000541419	0.020279163642627846
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020279163642627846
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627846
GALACTOSIALIDOSIS	0.000541419	0.020279163642627846
GM1 GANGLIOSIDOSIS	0.000541419	0.020279163642627846
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020279163642627846
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020279163642627846
GLIOBLASTOMA	0.000541419	0.020279163642627846
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627846
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020279163642627846
CLASSIC HOMOCYSTINURIA	0.000541419	0.020279163642627846
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020279163642627846
HYPERPROLINEMIA TYPE 1	0.000541419	0.020279163642627846
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020279163642627846
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627846
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020279163642627846
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020279163642627846
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.020279163642627846
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020279163642627846
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020279163642627846
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020279163642627846
ATAXIA-TELANGIECTASIA	0.000541419	0.020279163642627846
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020279163642627846
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020279163642627846
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627846
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020279163642627846
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020279163642627846
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020279163642627846
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020279163642627846
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020279163642627846
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020279163642627846
TENORIO SYNDROME; TNORS	0.000541419	0.020279163642627846
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020279163642627846
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020279163642627846
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020279163642627846
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020279163642627846
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020279163642627846
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020279163642627846
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020279163642627846
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020279163642627846
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020279163642627846
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020279163642627846
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020279163642627846
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020279163642627846
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020279163642627846
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020279163642627846
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020279163642627846
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020279163642627846
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020279163642627846
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020279163642627846
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020279163642627846
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020279163642627846
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020279163642627846
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020279163642627846
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020279163642627846
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020279163642627846
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.020279163642627846
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.020279163642627846
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020279163642627846
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020279163642627846
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020279163642627846
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020279163642627846
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020279163642627846
EPISODIC ATAXIA TYPE 6	0.000541419	0.020279163642627846
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020279163642627846
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020279163642627846
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020279163642627846
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020279163642627846
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020279163642627846
CONGENITAL HYDROCEPHALUS	0.000541419	0.020279163642627846
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020279163642627846
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020279163642627846
FRONTAL ENCEPHALOCELE	0.000541419	0.020279163642627846
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020279163642627846
BETA-MANNOSIDOSIS	0.000541419	0.020279163642627846
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020279163642627846
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020279163642627846
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020279163642627846
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020279163642627846
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020279163642627846
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020279163642627846
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020279163642627846
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020279163642627846
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020279163642627846
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020279163642627846
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020279163642627846
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020279163642627846
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020279163642627846
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020279163642627846
CRISPONI SYNDROME	0.000541419	0.020279163642627846
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020279163642627846
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020279163642627846
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020279163642627846
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020279163642627846
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020279163642627846
DISTAL TRISOMY 15Q	0.000541419	0.020279163642627846
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020279163642627846
FAMILIAL DYSAUTONOMIA	0.000541419	0.020279163642627846
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020279163642627846
